id	sid	tid	token	lemma	pos
iajs-3338	1	1	19	19	NUM
iajs-3338	1	2	©	©	PROPN
iajs-3338	1	3	2022	2022	NUM
iajs-3338	1	4	the	the	DET
iajs-3338	1	5	author(s	author(s	NOUN
iajs-3338	1	6	)	)	PUNCT
iajs-3338	1	7	.	.	PUNCT
iajs-3338	2	1	published	publish	VERB
iajs-3338	2	2	by	by	ADP
iajs-3338	2	3	college	college	NOUN
iajs-3338	2	4	of	of	ADP
iajs-3338	2	5	education	education	NOUN
iajs-3338	2	6	for	for	ADP
iajs-3338	2	7	pure	pure	ADJ
iajs-3338	2	8	science	science	NOUN
iajs-3338	2	9	(	(	PUNCT
iajs-3338	2	10	ibn	ibn	PROPN
iajs-3338	2	11	al	al	PROPN
iajs-3338	2	12	-	-	PUNCT
iajs-3338	2	13	haitham	haitham	PROPN
iajs-3338	2	14	)	)	PUNCT
iajs-3338	2	15	,	,	PUNCT
iajs-3338	2	16	university	university	NOUN
iajs-3338	2	17	of	of	ADP
iajs-3338	2	18	baghdad	baghdad	PROPN
iajs-3338	2	19	.	.	PUNCT
iajs-3338	3	1	this	this	PRON
iajs-3338	3	2	is	be	AUX
iajs-3338	3	3	an	an	DET
iajs-3338	3	4	open	open	ADJ
iajs-3338	3	5	-	-	PUNCT
iajs-3338	3	6	access	access	NOUN
iajs-3338	3	7	article	article	NOUN
iajs-3338	3	8	distributed	distribute	VERB
iajs-3338	3	9	under	under	ADP
iajs-3338	3	10	the	the	DET
iajs-3338	3	11	terms	term	NOUN
iajs-3338	3	12	of	of	ADP
iajs-3338	3	13	the	the	DET
iajs-3338	3	14	creative	creative	ADJ
iajs-3338	3	15	commons	common	NOUN
iajs-3338	3	16	attribution	attribution	NOUN
iajs-3338	3	17	4.0	4.0	NUM
iajs-3338	3	18	international	international	ADJ
iajs-3338	3	19	license	license	NOUN
iajs-3338	3	20	evaluation	evaluation	NOUN
iajs-3338	3	21	of	of	ADP
iajs-3338	3	22	salivary	salivary	ADJ
iajs-3338	3	23	interleukin	interleukin	NOUN
iajs-3338	3	24	2	2	NUM
iajs-3338	3	25	(	(	PUNCT
iajs-3338	3	26	il-2	il-2	NUM
iajs-3338	3	27	)	)	PUNCT
iajs-3338	3	28	and	and	CCONJ
iajs-3338	3	29	interleukin	interleukin	NOUN
iajs-3338	3	30	12(il-12	12(il-12	NOUN
iajs-3338	3	31	)	)	PUNCT
iajs-3338	3	32	in	in	ADP
iajs-3338	3	33	recurrent	recurrent	ADJ
iajs-3338	3	34	aphthous	aphthous	ADJ
iajs-3338	3	35	stomatitis	stomatitis	NOUN
iajs-3338	3	36	sura	sura	NOUN
iajs-3338	3	37	farhan	farhan	PROPN
iajs-3338	3	38	saeed1	saeed1	PROPN
iajs-3338	3	39	,	,	PUNCT
iajs-3338	3	40	*	*	PUNCT
iajs-3338	3	41	and	and	CCONJ
iajs-3338	3	42	zainab	zainab	PROPN
iajs-3338	3	43	abduljabar	abduljabar	NOUN
iajs-3338	3	44	aldhaher2	aldhaher2	PUNCT
iajs-3338	4	1	1,2department	1,2department	NUM
iajs-3338	4	2	of	of	ADP
iajs-3338	4	3	basic	basic	ADJ
iajs-3338	4	4	sciences	science	NOUN
iajs-3338	4	5	,	,	PUNCT
iajs-3338	4	6	college	college	NOUN
iajs-3338	4	7	of	of	ADP
iajs-3338	4	8	dentistry	dentistry	NOUN
iajs-3338	4	9	,	,	PUNCT
iajs-3338	4	10	university	university	NOUN
iajs-3338	4	11	of	of	ADP
iajs-3338	4	12	baghdad	baghdad	PROPN
iajs-3338	4	13	,	,	PUNCT
iajs-3338	4	14	baghdad	baghdad	PROPN
iajs-3338	4	15	,	,	PUNCT
iajs-3338	4	16	iraq	iraq	PROPN
iajs-3338	4	17	.	.	PUNCT
iajs-3338	5	1	*	*	PUNCT
iajs-3338	5	2	corresponding	correspond	VERB
iajs-3338	5	3	author	author	NOUN
iajs-3338	5	4	.	.	PUNCT
iajs-3338	6	1	received	receive	VERB
iajs-3338	6	2	:	:	PUNCT
iajs-3338	6	3	14	14	NUM
iajs-3338	6	4	march	march	NOUN
iajs-3338	6	5	2023	2023	NUM
iajs-3338	6	6	accepted	accept	VERB
iajs-3338	6	7	:	:	PUNCT
iajs-3338	6	8	4	4	NUM
iajs-3338	6	9	may	may	PROPN
iajs-3338	6	10	2023	2023	NUM
iajs-3338	6	11	published	publish	VERB
iajs-3338	6	12	:	:	PUNCT
iajs-3338	6	13	20	20	NUM
iajs-3338	6	14	october	october	NOUN
iajs-3338	6	15	2024	2024	NUM
iajs-3338	6	16	doi.org/10.30526/37.4.3338	doi.org/10.30526/37.4.3338	NOUN
iajs-3338	6	17	abstract	abstract	ADJ
iajs-3338	6	18	recurrent	recurrent	ADJ
iajs-3338	6	19	aphthous	aphthous	ADJ
iajs-3338	6	20	stomatitis	stomatitis	NOUN
iajs-3338	6	21	(	(	PUNCT
iajs-3338	6	22	ras	ras	NOUN
iajs-3338	6	23	)	)	PUNCT
iajs-3338	6	24	is	be	AUX
iajs-3338	6	25	a	a	DET
iajs-3338	6	26	common	common	ADJ
iajs-3338	6	27	kind	kind	NOUN
iajs-3338	6	28	of	of	ADP
iajs-3338	6	29	excruciating	excruciating	ADJ
iajs-3338	6	30	mouth	mouth	NOUN
iajs-3338	6	31	mucosal	mucosal	NOUN
iajs-3338	6	32	disease	disease	NOUN
iajs-3338	6	33	.	.	PUNCT
iajs-3338	7	1	despite	despite	SCONJ
iajs-3338	7	2	their	their	PRON
iajs-3338	7	3	high	high	ADJ
iajs-3338	7	4	prevalence	prevalence	NOUN
iajs-3338	7	5	,	,	PUNCT
iajs-3338	7	6	etiopathogenesis	etiopathogenesis	NOUN
iajs-3338	7	7	remains	remain	VERB
iajs-3338	7	8	unclear	unclear	ADJ
iajs-3338	7	9	.	.	PUNCT
iajs-3338	8	1	this	this	DET
iajs-3338	8	2	study	study	NOUN
iajs-3338	8	3	was	be	AUX
iajs-3338	8	4	to	to	PART
iajs-3338	8	5	investigate	investigate	VERB
iajs-3338	8	6	the	the	DET
iajs-3338	8	7	concentration	concentration	NOUN
iajs-3338	8	8	of	of	ADP
iajs-3338	8	9	interleukin	interleukin	NOUN
iajs-3338	8	10	2	2	NUM
iajs-3338	8	11	(	(	PUNCT
iajs-3338	8	12	il-2	il-2	NUM
iajs-3338	8	13	)	)	PUNCT
iajs-3338	8	14	and	and	CCONJ
iajs-3338	8	15	interleukin	interleukin	NOUN
iajs-3338	8	16	12	12	NUM
iajs-3338	8	17	(	(	PUNCT
iajs-3338	8	18	il-12	il-12	NOUN
iajs-3338	8	19	)	)	PUNCT
iajs-3338	8	20	in	in	ADP
iajs-3338	8	21	the	the	DET
iajs-3338	8	22	saliva	saliva	NOUN
iajs-3338	8	23	of	of	ADP
iajs-3338	8	24	ras	ras	PROPN
iajs-3338	8	25	.	.	PROPN
iajs-3338	8	26	eighty	eighty	NUM
iajs-3338	8	27	people	people	NOUN
iajs-3338	8	28	were	be	AUX
iajs-3338	8	29	involved	involve	VERB
iajs-3338	8	30	in	in	ADP
iajs-3338	8	31	this	this	DET
iajs-3338	8	32	study	study	NOUN
iajs-3338	8	33	(	(	PUNCT
iajs-3338	8	34	forty	forty	NUM
iajs-3338	8	35	ras	ras	NOUN
iajs-3338	8	36	patients	patient	NOUN
iajs-3338	8	37	and	and	CCONJ
iajs-3338	8	38	forty	forty	NUM
iajs-3338	8	39	healthy	healthy	ADJ
iajs-3338	8	40	controls	control	NOUN
iajs-3338	8	41	)	)	PUNCT
iajs-3338	8	42	,	,	PUNCT
iajs-3338	8	43	their	their	PRON
iajs-3338	8	44	ages	age	NOUN
iajs-3338	8	45	ranged	range	VERB
iajs-3338	8	46	(	(	PUNCT
iajs-3338	8	47	from	from	ADP
iajs-3338	8	48	16	16	NUM
iajs-3338	8	49	60	60	NUM
iajs-3338	8	50	)	)	PUNCT
iajs-3338	8	51	years	year	NOUN
iajs-3338	8	52	.	.	PUNCT
iajs-3338	9	1	the	the	DET
iajs-3338	9	2	sandwich	sandwich	NOUN
iajs-3338	9	3	enzyme	enzyme	NOUN
iajs-3338	9	4	-	-	PUNCT
iajs-3338	9	5	linked	link	VERB
iajs-3338	9	6	immune	immune	NOUN
iajs-3338	9	7	-	-	PUNCT
iajs-3338	9	8	sorbent	sorbent	NOUN
iajs-3338	9	9	assay	assay	NOUN
iajs-3338	9	10	was	be	AUX
iajs-3338	9	11	used	use	VERB
iajs-3338	9	12	to	to	PART
iajs-3338	9	13	assess	assess	VERB
iajs-3338	9	14	interleukin	interleukin	NOUN
iajs-3338	9	15	2	2	NUM
iajs-3338	9	16	(	(	PUNCT
iajs-3338	9	17	il-2	il-2	NUM
iajs-3338	9	18	)	)	PUNCT
iajs-3338	9	19	and	and	CCONJ
iajs-3338	9	20	interleukin	interleukin	NOUN
iajs-3338	9	21	12	12	NUM
iajs-3338	9	22	(	(	PUNCT
iajs-3338	9	23	il-12	il-12	NOUN
iajs-3338	9	24	)	)	PUNCT
iajs-3338	9	25	concentrations	concentration	NOUN
iajs-3338	9	26	in	in	ADP
iajs-3338	9	27	saliva	saliva	NOUN
iajs-3338	9	28	in	in	ADP
iajs-3338	9	29	each	each	DET
iajs-3338	9	30	group	group	NOUN
iajs-3338	9	31	.	.	PUNCT
iajs-3338	10	1	the	the	DET
iajs-3338	10	2	salivary	salivary	ADJ
iajs-3338	10	3	concentrations	concentration	NOUN
iajs-3338	10	4	of	of	ADP
iajs-3338	10	5	interleukin	interleukin	NOUN
iajs-3338	10	6	2	2	NUM
iajs-3338	10	7	(	(	PUNCT
iajs-3338	10	8	il-2	il-2	NUM
iajs-3338	10	9	)	)	PUNCT
iajs-3338	10	10	and	and	CCONJ
iajs-3338	10	11	interleukin	interleukin	NOUN
iajs-3338	10	12	12	12	NUM
iajs-3338	10	13	(	(	PUNCT
iajs-3338	10	14	il-12	il-12	NOUN
iajs-3338	10	15	)	)	PUNCT
iajs-3338	10	16	was	be	AUX
iajs-3338	10	17	significantly	significantly	ADV
iajs-3338	10	18	higher	high	ADJ
iajs-3338	10	19	in	in	ADP
iajs-3338	10	20	the	the	DET
iajs-3338	10	21	patient	patient	NOUN
iajs-3338	10	22	group	group	NOUN
iajs-3338	10	23	(	(	PUNCT
iajs-3338	10	24	159.06±20.37	159.06±20.37	NUM
iajs-3338	10	25	)	)	PUNCT
iajs-3338	10	26	,	,	PUNCT
iajs-3338	10	27	(	(	PUNCT
iajs-3338	10	28	331.32±94.42	331.32±94.42	NUM
iajs-3338	10	29	)	)	PUNCT
iajs-3338	10	30	respectively	respectively	ADV
iajs-3338	10	31	in	in	ADP
iajs-3338	10	32	comparison	comparison	NOUN
iajs-3338	10	33	to	to	ADP
iajs-3338	10	34	the	the	DET
iajs-3338	10	35	control	control	NOUN
iajs-3338	10	36	group	group	NOUN
iajs-3338	10	37	at	at	ADP
iajs-3338	10	38	(	(	PUNCT
iajs-3338	10	39	p≤0.05	p≤0.05	NOUN
iajs-3338	10	40	)	)	PUNCT
iajs-3338	10	41	.	.	PUNCT
iajs-3338	11	1	these	these	DET
iajs-3338	11	2	results	result	NOUN
iajs-3338	11	3	indicate	indicate	VERB
iajs-3338	11	4	that	that	SCONJ
iajs-3338	11	5	saliva	saliva	NOUN
iajs-3338	11	6	provides	provide	VERB
iajs-3338	11	7	the	the	DET
iajs-3338	11	8	perfect	perfect	ADJ
iajs-3338	11	9	medium	medium	NOUN
iajs-3338	11	10	for	for	ADP
iajs-3338	11	11	the	the	DET
iajs-3338	11	12	detection	detection	NOUN
iajs-3338	11	13	of	of	ADP
iajs-3338	11	14	proinflammatory	proinflammatory	ADJ
iajs-3338	11	15	markers	marker	NOUN
iajs-3338	11	16	of	of	ADP
iajs-3338	11	17	the	the	DET
iajs-3338	11	18	oral	oral	ADJ
iajs-3338	11	19	cavity	cavity	NOUN
iajs-3338	11	20	,	,	PUNCT
iajs-3338	11	21	additionally	additionally	ADV
iajs-3338	11	22	,	,	PUNCT
iajs-3338	11	23	salivary	salivary	ADJ
iajs-3338	11	24	interleukin	interleukin	NOUN
iajs-3338	11	25	2	2	NUM
iajs-3338	11	26	(	(	PUNCT
iajs-3338	11	27	il-2	il-2	NUM
iajs-3338	11	28	)	)	PUNCT
iajs-3338	11	29	and	and	CCONJ
iajs-3338	11	30	interleukin	interleukin	NOUN
iajs-3338	11	31	12	12	NUM
iajs-3338	11	32	(	(	PUNCT
iajs-3338	11	33	il-12	il-12	NOUN
iajs-3338	11	34	)	)	PUNCT
iajs-3338	11	35	may	may	AUX
iajs-3338	11	36	play	play	VERB
iajs-3338	11	37	a	a	DET
iajs-3338	11	38	significant	significant	ADJ
iajs-3338	11	39	role	role	NOUN
iajs-3338	11	40	in	in	ADP
iajs-3338	11	41	the	the	DET
iajs-3338	11	42	pathophysiology	pathophysiology	NOUN
iajs-3338	11	43	of	of	ADP
iajs-3338	11	44	this	this	DET
iajs-3338	11	45	illness	illness	NOUN
iajs-3338	11	46	.	.	PUNCT
iajs-3338	12	1	keywords	keyword	NOUN
iajs-3338	12	2	:	:	PUNCT
iajs-3338	12	3	recurrent	recurrent	ADJ
iajs-3338	12	4	aphthous	aphthous	ADJ
iajs-3338	12	5	stomatitis	stomatitis	NOUN
iajs-3338	12	6	,	,	PUNCT
iajs-3338	12	7	salivary	salivary	ADJ
iajs-3338	12	8	evaluation	evaluation	NOUN
iajs-3338	12	9	,	,	PUNCT
iajs-3338	12	10	interleukin	interleukin	NOUN
iajs-3338	12	11	.	.	PUNCT
iajs-3338	13	1	1	1	X
iajs-3338	13	2	.	.	X
iajs-3338	13	3	introduction	introduction	NOUN
iajs-3338	13	4	until	until	ADP
iajs-3338	13	5	now	now	ADV
iajs-3338	13	6	,	,	PUNCT
iajs-3338	13	7	the	the	DET
iajs-3338	13	8	etiology	etiology	NOUN
iajs-3338	13	9	of	of	ADP
iajs-3338	13	10	recurrent	recurrent	ADJ
iajs-3338	13	11	aphthous	aphthous	ADJ
iajs-3338	13	12	stomatitis	stomatitis	NOUN
iajs-3338	13	13	(	(	PUNCT
iajs-3338	13	14	ras	ras	NOUN
iajs-3338	13	15	)	)	PUNCT
iajs-3338	13	16	has	have	AUX
iajs-3338	13	17	remained	remain	VERB
iajs-3338	13	18	unknown	unknown	ADJ
iajs-3338	13	19	,	,	PUNCT
iajs-3338	13	20	although	although	SCONJ
iajs-3338	13	21	genetic	genetic	ADJ
iajs-3338	13	22	susceptibility	susceptibility	NOUN
iajs-3338	13	23	,	,	PUNCT
iajs-3338	13	24	infectious	infectious	ADJ
iajs-3338	13	25	agents	agent	NOUN
iajs-3338	13	26	,	,	PUNCT
iajs-3338	13	27	and	and	CCONJ
iajs-3338	13	28	alterations	alteration	NOUN
iajs-3338	13	29	in	in	ADP
iajs-3338	13	30	immune	immune	ADJ
iajs-3338	13	31	mechanics	mechanic	NOUN
iajs-3338	13	32	have	have	AUX
iajs-3338	13	33	been	be	AUX
iajs-3338	13	34	implicated	implicate	VERB
iajs-3338	13	35	[	[	X
iajs-3338	13	36	1	1	NUM
iajs-3338	13	37	,	,	PUNCT
iajs-3338	13	38	2	2	NUM
iajs-3338	13	39	]	]	PUNCT
iajs-3338	13	40	.	.	PUNCT
iajs-3338	14	1	recurrent	recurrent	ADJ
iajs-3338	14	2	aphthous	aphthous	ADJ
iajs-3338	14	3	stomatitis	stomatitis	NOUN
iajs-3338	14	4	(	(	PUNCT
iajs-3338	14	5	ras	ras	NOUN
iajs-3338	14	6	)	)	PUNCT
iajs-3338	14	7	is	be	AUX
iajs-3338	14	8	a	a	DET
iajs-3338	14	9	prevalent	prevalent	ADJ
iajs-3338	14	10	oral	oral	ADJ
iajs-3338	14	11	mucosal	mucosal	NOUN
iajs-3338	14	12	disease	disease	NOUN
iajs-3338	14	13	characterized	characterize	VERB
iajs-3338	14	14	by	by	ADP
iajs-3338	14	15	a	a	DET
iajs-3338	14	16	yellowish	yellowish	ADJ
iajs-3338	14	17	-	-	PUNCT
iajs-3338	14	18	gray	gray	ADJ
iajs-3338	14	19	base	base	NOUN
iajs-3338	14	20	with	with	ADP
iajs-3338	14	21	elevated	elevated	ADJ
iajs-3338	14	22	margins	margin	NOUN
iajs-3338	14	23	and	and	CCONJ
iajs-3338	14	24	an	an	DET
iajs-3338	14	25	erythematous	erythematous	ADJ
iajs-3338	14	26	halo	halo	NOUN
iajs-3338	14	27	.	.	PUNCT
iajs-3338	15	1	ras	ras	X
iajs-3338	15	2	typically	typically	ADV
iajs-3338	15	3	manifests	manifest	VERB
iajs-3338	15	4	in	in	ADP
iajs-3338	15	5	the	the	DET
iajs-3338	15	6	lining	lining	NOUN
iajs-3338	15	7	or	or	CCONJ
iajs-3338	15	8	mucosa	mucosa	NOUN
iajs-3338	15	9	that	that	PRON
iajs-3338	15	10	is	be	AUX
iajs-3338	15	11	not	not	PART
iajs-3338	15	12	keratinized	keratinize	VERB
iajs-3338	15	13	[	[	PUNCT
iajs-3338	15	14	3	3	NUM
iajs-3338	15	15	,	,	PUNCT
iajs-3338	15	16	4	4	NUM
iajs-3338	15	17	]	]	PUNCT
iajs-3338	15	18	.	.	PUNCT
iajs-3338	16	1	it	it	PRON
iajs-3338	16	2	has	have	VERB
iajs-3338	16	3	a	a	DET
iajs-3338	16	4	prevalence	prevalence	NOUN
iajs-3338	16	5	of	of	ADP
iajs-3338	16	6	50	50	NUM
iajs-3338	16	7	–	–	PUNCT
iajs-3338	16	8	66	66	NUM
iajs-3338	16	9	%	%	NOUN
iajs-3338	16	10	and	and	CCONJ
iajs-3338	16	11	it	it	PRON
iajs-3338	16	12	is	be	AUX
iajs-3338	16	13	one	one	NUM
iajs-3338	16	14	of	of	ADP
iajs-3338	16	15	the	the	DET
iajs-3338	16	16	most	most	ADV
iajs-3338	16	17	prevalent	prevalent	ADJ
iajs-3338	16	18	conditions	condition	NOUN
iajs-3338	16	19	affecting	affect	VERB
iajs-3338	16	20	the	the	DET
iajs-3338	16	21	oral	oral	ADJ
iajs-3338	16	22	mucosa	mucosa	NOUN
iajs-3338	17	1	[	[	X
iajs-3338	17	2	5	5	NUM
iajs-3338	17	3	,	,	PUNCT
iajs-3338	17	4	6	6	NUM
iajs-3338	17	5	]	]	PUNCT
iajs-3338	17	6	.	.	PUNCT
iajs-3338	18	1	recurrent	recurrent	ADJ
iajs-3338	18	2	aphthous	aphthous	ADJ
iajs-3338	18	3	stomatitis	stomatitis	NOUN
iajs-3338	18	4	is	be	AUX
iajs-3338	18	5	frequently	frequently	ADV
iajs-3338	18	6	observed	observe	VERB
iajs-3338	18	7	and	and	CCONJ
iajs-3338	18	8	is	be	AUX
iajs-3338	18	9	immune	immune	NOUN
iajs-3338	18	10	-	-	PUNCT
iajs-3338	18	11	mediated	mediate	VERB
iajs-3338	19	1	[	[	X
iajs-3338	19	2	7	7	NUM
iajs-3338	19	3	,	,	PUNCT
iajs-3338	19	4	8	8	NUM
iajs-3338	19	5	]	]	PUNCT
iajs-3338	19	6	.	.	PUNCT
iajs-3338	20	1	ras	ras	PROPN
iajs-3338	20	2	can	can	AUX
iajs-3338	20	3	be	be	AUX
iajs-3338	20	4	managed	manage	VERB
iajs-3338	20	5	through	through	ADP
iajs-3338	20	6	a	a	DET
iajs-3338	20	7	wide	wide	ADJ
iajs-3338	20	8	variety	variety	NOUN
iajs-3338	20	9	of	of	ADP
iajs-3338	20	10	preventative	preventative	ADJ
iajs-3338	20	11	measures	measure	NOUN
iajs-3338	20	12	and	and	CCONJ
iajs-3338	20	13	therapies	therapy	NOUN
iajs-3338	20	14	,	,	PUNCT
iajs-3338	20	15	intending	intend	VERB
iajs-3338	20	16	to	to	PART
iajs-3338	20	17	reduce	reduce	VERB
iajs-3338	20	18	ulcer	ulcer	NOUN
iajs-3338	20	19	pain	pain	NOUN
iajs-3338	20	20	,	,	PUNCT
iajs-3338	20	21	stimulate	stimulate	VERB
iajs-3338	20	22	ulcer	ulcer	NOUN
iajs-3338	20	23	healing	healing	NOUN
iajs-3338	20	24	,	,	PUNCT
iajs-3338	20	25	and/or	and/or	CCONJ
iajs-3338	20	26	prevent	prevent	VERB
iajs-3338	20	27	ulcer	ulcer	NOUN
iajs-3338	20	28	recurrence	recurrence	NOUN
iajs-3338	20	29	[	[	X
iajs-3338	20	30	9	9	NUM
iajs-3338	20	31	]	]	PUNCT
iajs-3338	20	32	.	.	PUNCT
iajs-3338	21	1	first	first	ADJ
iajs-3338	21	2	-	-	PUNCT
iajs-3338	21	3	line	line	NOUN
iajs-3338	21	4	treatment	treatment	NOUN
iajs-3338	21	5	options	option	NOUN
iajs-3338	21	6	include	include	VERB
iajs-3338	21	7	topical	topical	ADJ
iajs-3338	21	8	medications	medication	NOUN
iajs-3338	21	9	in	in	ADP
iajs-3338	21	10	the	the	DET
iajs-3338	21	11	form	form	NOUN
iajs-3338	21	12	of	of	ADP
iajs-3338	21	13	corticosteroids	corticosteroid	NOUN
iajs-3338	21	14	(	(	PUNCT
iajs-3338	21	15	triamcinolone	triamcinolone	NOUN
iajs-3338	21	16	acetonide	acetonide	NOUN
iajs-3338	21	17	)	)	PUNCT
iajs-3338	21	18	,	,	PUNCT
iajs-3338	21	19	anti	anti	ADJ
iajs-3338	21	20	-	-	ADJ
iajs-3338	21	21	inflammatory	inflammatory	ADJ
iajs-3338	21	22	drugs	drug	NOUN
iajs-3338	21	23	(	(	PUNCT
iajs-3338	21	24	amlexanox	amlexanox	NOUN
iajs-3338	21	25	)	)	PUNCT
iajs-3338	21	26	,	,	PUNCT
iajs-3338	21	27	antibiotics	antibiotic	NOUN
iajs-3338	21	28	(	(	PUNCT
iajs-3338	21	29	doxycycline	doxycycline	NOUN
iajs-3338	21	30	)	)	PUNCT
iajs-3338	21	31	,	,	PUNCT
iajs-3338	21	32	and	and	CCONJ
iajs-3338	21	33	antiseptics	antiseptic	NOUN
iajs-3338	21	34	(	(	PUNCT
iajs-3338	21	35	lidocaine	lidocaine	NOUN
iajs-3338	21	36	)	)	PUNCT
iajs-3338	22	1	[	[	X
iajs-3338	22	2	10	10	NUM
iajs-3338	22	3	]	]	PUNCT
iajs-3338	22	4	.	.	PUNCT
iajs-3338	23	1	in	in	ADP
iajs-3338	23	2	more	more	ADV
iajs-3338	23	3	severe	severe	ADJ
iajs-3338	23	4	cases	case	NOUN
iajs-3338	23	5	of	of	ADP
iajs-3338	23	6	ras	ras	PUNCT
iajs-3338	23	7	where	where	SCONJ
iajs-3338	23	8	local	local	ADJ
iajs-3338	23	9	treatment	treatment	NOUN
iajs-3338	23	10	is	be	AUX
iajs-3338	23	11	insufficient	insufficient	ADJ
iajs-3338	23	12	,	,	PUNCT
iajs-3338	23	13	systemic	systemic	ADJ
iajs-3338	23	14	drugs	drug	NOUN
iajs-3338	23	15	in	in	ADP
iajs-3338	23	16	the	the	DET
iajs-3338	23	17	form	form	NOUN
iajs-3338	23	18	of	of	ADP
iajs-3338	23	19	corticosteroids	corticosteroid	NOUN
iajs-3338	23	20	(	(	PUNCT
iajs-3338	23	21	prednisone	prednisone	NOUN
iajs-3338	23	22	)	)	PUNCT
iajs-3338	23	23	,	,	PUNCT
iajs-3338	23	24	immunomodulatory	immunomodulatory	ADJ
iajs-3338	23	25	drugs	drug	NOUN
iajs-3338	23	26	(	(	PUNCT
iajs-3338	23	27	thalidomide	thalidomide	NOUN
iajs-3338	23	28	)	)	PUNCT
iajs-3338	23	29	,	,	PUNCT
iajs-3338	23	30	and	and	CCONJ
iajs-3338	23	31	antibiotics	antibiotic	NOUN
iajs-3338	23	32	/	/	SYM
iajs-3338	23	33	antimicrobials	antimicrobial	NOUN
iajs-3338	23	34	(	(	PUNCT
iajs-3338	23	35	clofazimine	clofazimine	NOUN
iajs-3338	23	36	)	)	PUNCT
iajs-3338	23	37	can	can	AUX
iajs-3338	23	38	prove	prove	VERB
iajs-3338	23	39	effective	effective	ADJ
iajs-3338	23	40	[	[	X
iajs-3338	23	41	11	11	NUM
iajs-3338	23	42	]	]	PUNCT
iajs-3338	23	43	.	.	PUNCT
iajs-3338	24	1	because	because	SCONJ
iajs-3338	24	2	they	they	PRON
iajs-3338	24	3	are	be	AUX
iajs-3338	24	4	essential	essential	ADJ
iajs-3338	24	5	mediators	mediator	NOUN
iajs-3338	24	6	of	of	ADP
iajs-3338	24	7	the	the	DET
iajs-3338	24	8	immune	immune	ADJ
iajs-3338	24	9	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3338	24	10	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3338	24	11	https://orcid.org/0009-0007-2122-8046	https://orcid.org/0009-0007-2122-8046	PROPN
iajs-3338	24	12	mailto:surafarhan6@gmail.com	mailto:surafarhan6@gmail.com	PROPN
iajs-3338	24	13	https://orcid.org/0000-0002-8977-8761	https://orcid.org/0000-0002-8977-8761	PROPN
iajs-3338	24	14	mailto:zainab.aldhahir@codental.uobaghdad.edu.iq	mailto:zainab.aldhahir@codental.uobaghdad.edu.iq	PROPN
iajs-3338	24	15	ihjpas	ihjpas	PROPN
iajs-3338	24	16	.	.	PUNCT
iajs-3338	25	1	2024	2024	NUM
iajs-3338	25	2	,	,	PUNCT
iajs-3338	25	3	37(4	37(4	NOUN
iajs-3338	25	4	)	)	PUNCT
iajs-3338	25	5	20	20	NUM
iajs-3338	25	6	response	response	NOUN
iajs-3338	25	7	,	,	PUNCT
iajs-3338	25	8	cytokines	cytokine	NOUN
iajs-3338	25	9	have	have	AUX
iajs-3338	25	10	received	receive	VERB
iajs-3338	25	11	a	a	DET
iajs-3338	25	12	lot	lot	NOUN
iajs-3338	25	13	of	of	ADP
iajs-3338	25	14	attention	attention	NOUN
iajs-3338	25	15	in	in	ADP
iajs-3338	25	16	the	the	DET
iajs-3338	25	17	immunological	immunological	ADJ
iajs-3338	25	18	pathophysiology	pathophysiology	NOUN
iajs-3338	25	19	of	of	ADP
iajs-3338	25	20	ras	ras	PROPN
iajs-3338	25	21	[	[	X
iajs-3338	25	22	12	12	NUM
iajs-3338	25	23	]	]	PUNCT
iajs-3338	25	24	.	.	PUNCT
iajs-3338	26	1	recent	recent	ADJ
iajs-3338	26	2	studies	study	NOUN
iajs-3338	26	3	suggest	suggest	VERB
iajs-3338	26	4	that	that	SCONJ
iajs-3338	26	5	ras	ras	PROPN
iajs-3338	26	6	may	may	AUX
iajs-3338	26	7	be	be	AUX
iajs-3338	26	8	brought	bring	VERB
iajs-3338	26	9	on	on	ADP
iajs-3338	26	10	by	by	ADP
iajs-3338	26	11	a	a	DET
iajs-3338	26	12	cellular	cellular	ADJ
iajs-3338	26	13	defect	defect	NOUN
iajs-3338	26	14	in	in	ADP
iajs-3338	26	15	the	the	DET
iajs-3338	26	16	oral	oral	ADJ
iajs-3338	26	17	mucosa	mucosa	NOUN
iajs-3338	26	18	membrane	membrane	NOUN
iajs-3338	26	19	,	,	PUNCT
iajs-3338	26	20	which	which	PRON
iajs-3338	26	21	results	result	VERB
iajs-3338	26	22	in	in	ADP
iajs-3338	26	23	a	a	DET
iajs-3338	26	24	cellular	cellular	ADJ
iajs-3338	26	25	immune	immune	ADJ
iajs-3338	26	26	response	response	NOUN
iajs-3338	26	27	focused	focus	VERB
iajs-3338	26	28	on	on	ADP
iajs-3338	26	29	the	the	DET
iajs-3338	26	30	portion	portion	NOUN
iajs-3338	26	31	of	of	ADP
iajs-3338	26	32	the	the	DET
iajs-3338	26	33	oral	oral	ADJ
iajs-3338	26	34	mucosa	mucosa	NOUN
iajs-3338	26	35	membrane	membrane	NOUN
iajs-3338	26	36	at	at	ADP
iajs-3338	26	37	its	its	PRON
iajs-3338	26	38	center	center	NOUN
iajs-3338	27	1	[	[	X
iajs-3338	27	2	13	13	NUM
iajs-3338	27	3	-	-	SYM
iajs-3338	27	4	16	16	NUM
iajs-3338	27	5	]	]	PUNCT
iajs-3338	27	6	.	.	PUNCT
iajs-3338	28	1	two	two	NUM
iajs-3338	28	2	different	different	ADJ
iajs-3338	28	3	types	type	NOUN
iajs-3338	28	4	of	of	ADP
iajs-3338	28	5	cytokines	cytokine	NOUN
iajs-3338	28	6	pro	pro	ADJ
iajs-3338	28	7	-	-	ADJ
iajs-3338	28	8	inflammatory	inflammatory	ADJ
iajs-3338	28	9	cytokines	cytokine	NOUN
iajs-3338	28	10	that	that	PRON
iajs-3338	28	11	induce	induce	VERB
iajs-3338	28	12	cell	cell	NOUN
iajs-3338	28	13	-	-	PUNCT
iajs-3338	28	14	mediated	mediate	VERB
iajs-3338	28	15	immunity	immunity	NOUN
iajs-3338	28	16	and	and	CCONJ
iajs-3338	28	17	are	be	AUX
iajs-3338	28	18	produced	produce	VERB
iajs-3338	28	19	by	by	ADP
iajs-3338	28	20	th1	th1	PROPN
iajs-3338	28	21	(	(	PUNCT
iajs-3338	28	22	il-2	il-2	PROPN
iajs-3338	28	23	,	,	PUNCT
iajs-3338	28	24	il-12	il-12	NOUN
iajs-3338	28	25	,	,	PUNCT
iajs-3338	28	26	ifn	ifn	PROPN
iajs-3338	28	27	-	-	PUNCT
iajs-3338	28	28	g	g	PROPN
iajs-3338	28	29	and	and	CCONJ
iajs-3338	28	30	tnf	tnf	PROPN
iajs-3338	28	31	-	-	PUNCT
iajs-3338	28	32	a	a	NOUN
iajs-3338	28	33	)	)	PUNCT
iajs-3338	28	34	and	and	CCONJ
iajs-3338	28	35	antiinflammatory	antiinflammatory	NOUN
iajs-3338	28	36	cytokines	cytokine	NOUN
iajs-3338	28	37	(	(	PUNCT
iajs-3338	28	38	il-4	il-4	X
iajs-3338	28	39	,	,	PUNCT
iajs-3338	28	40	il-5	il-5	PROPN
iajs-3338	28	41	,	,	PUNCT
iajs-3338	28	42	il-10	il-10	NOUN
iajs-3338	28	43	and	and	CCONJ
iajs-3338	28	44	il-13	il-13	PRON
iajs-3338	28	45	)	)	PUNCT
iajs-3338	28	46	produced	produce	VERB
iajs-3338	28	47	by	by	ADP
iajs-3338	28	48	th2	th2	PROPN
iajs-3338	28	49	and	and	CCONJ
iajs-3338	28	50	promote	promote	VERB
iajs-3338	28	51	humoral	humoral	ADJ
iajs-3338	28	52	immunity	immunity	NOUN
iajs-3338	28	53	and	and	CCONJ
iajs-3338	28	54	suppression	suppression	NOUN
iajs-3338	28	55	of	of	ADP
iajs-3338	28	56	cell	cell	NOUN
iajs-3338	28	57	-	-	PUNCT
iajs-3338	28	58	mediated	mediate	VERB
iajs-3338	28	59	immunity	immunity	NOUN
iajs-3338	28	60	[	[	X
iajs-3338	28	61	17	17	NUM
iajs-3338	28	62	,	,	PUNCT
iajs-3338	28	63	18	18	NUM
iajs-3338	28	64	]	]	PUNCT
iajs-3338	28	65	.	.	PUNCT
iajs-3338	29	1	the	the	DET
iajs-3338	29	2	imbalance	imbalance	NOUN
iajs-3338	29	3	of	of	ADP
iajs-3338	29	4	th1/	th1/	NUM
iajs-3338	29	5	th2	th2	PROPN
iajs-3338	29	6	immune	immune	ADJ
iajs-3338	29	7	response	response	NOUN
iajs-3338	29	8	is	be	AUX
iajs-3338	29	9	strongly	strongly	ADV
iajs-3338	29	10	influenced	influence	VERB
iajs-3338	29	11	by	by	ADP
iajs-3338	29	12	their	their	PRON
iajs-3338	29	13	cytokine	cytokine	ADJ
iajs-3338	29	14	environment	environment	NOUN
iajs-3338	29	15	[	[	X
iajs-3338	29	16	19	19	NUM
iajs-3338	29	17	]	]	PUNCT
iajs-3338	29	18	.	.	PUNCT
iajs-3338	30	1	to	to	PART
iajs-3338	30	2	fight	fight	VERB
iajs-3338	30	3	infections	infection	NOUN
iajs-3338	30	4	,	,	PUNCT
iajs-3338	30	5	cancers	cancer	NOUN
iajs-3338	30	6	and	and	CCONJ
iajs-3338	30	7	self	self	NOUN
iajs-3338	30	8	-	-	PUNCT
iajs-3338	30	9	antigens	antigen	NOUN
iajs-3338	30	10	,	,	PUNCT
iajs-3338	30	11	the	the	DET
iajs-3338	30	12	primary	primary	ADJ
iajs-3338	30	13	immune	immune	ADJ
iajs-3338	30	14	response	response	NOUN
iajs-3338	30	15	mediators	mediator	NOUN
iajs-3338	30	16	are	be	AUX
iajs-3338	30	17	cytokines	cytokine	NOUN
iajs-3338	30	18	.	.	PUNCT
iajs-3338	31	1	they	they	PRON
iajs-3338	31	2	have	have	VERB
iajs-3338	31	3	a	a	DET
iajs-3338	31	4	significant	significant	ADJ
iajs-3338	31	5	impact	impact	NOUN
iajs-3338	31	6	in	in	ADP
iajs-3338	31	7	examining	examine	VERB
iajs-3338	31	8	the	the	DET
iajs-3338	31	9	pathophysiology	pathophysiology	NOUN
iajs-3338	31	10	of	of	ADP
iajs-3338	31	11	immune	immune	ADJ
iajs-3338	31	12	responses	response	NOUN
iajs-3338	31	13	[	[	X
iajs-3338	31	14	20	20	NUM
iajs-3338	31	15	]	]	PUNCT
iajs-3338	31	16	.	.	PUNCT
iajs-3338	32	1	among	among	ADP
iajs-3338	32	2	the	the	DET
iajs-3338	32	3	cell	cell	NOUN
iajs-3338	32	4	types	type	NOUN
iajs-3338	32	5	that	that	PRON
iajs-3338	32	6	make	make	VERB
iajs-3338	32	7	cytokines	cytokine	NOUN
iajs-3338	32	8	are	be	AUX
iajs-3338	32	9	type	type	NOUN
iajs-3338	32	10	i	i	PRON
iajs-3338	32	11	and	and	CCONJ
iajs-3338	32	12	type	type	PROPN
iajs-3338	32	13	ii	ii	PROPN
iajs-3338	32	14	helper	helper	NOUN
iajs-3338	32	15	t	t	PROPN
iajs-3338	32	16	cells	cell	NOUN
iajs-3338	32	17	.	.	PUNCT
iajs-3338	33	1	t	t	X
iajs-3338	33	2	helper	helper	NOUN
iajs-3338	33	3	cells	cell	NOUN
iajs-3338	33	4	release	release	VERB
iajs-3338	33	5	two	two	NUM
iajs-3338	33	6	types	type	NOUN
iajs-3338	33	7	of	of	ADP
iajs-3338	33	8	cytokines	cytokine	NOUN
iajs-3338	33	9	:	:	PUNCT
iajs-3338	33	10	type	type	NOUN
iajs-3338	33	11	2	2	NUM
iajs-3338	33	12	(	(	PUNCT
iajs-3338	33	13	il-4	il-4	NOUN
iajs-3338	33	14	,	,	PUNCT
iajs-3338	33	15	il-5	il-5	PROPN
iajs-3338	33	16	,	,	PUNCT
iajs-3338	33	17	il-6	il-6	NUM
iajs-3338	33	18	,	,	PUNCT
iajs-3338	33	19	il-10	il-10	PRON
iajs-3338	33	20	,	,	PUNCT
iajs-3338	33	21	and	and	CCONJ
iajs-3338	33	22	il-13	il-13	NUM
iajs-3338	33	23	)	)	PUNCT
iajs-3338	33	24	,	,	PUNCT
iajs-3338	33	25	which	which	PRON
iajs-3338	33	26	improve	improve	VERB
iajs-3338	33	27	humoral	humoral	ADJ
iajs-3338	33	28	immunity	immunity	NOUN
iajs-3338	33	29	and	and	CCONJ
iajs-3338	33	30	tolerance	tolerance	NOUN
iajs-3338	33	31	,	,	PUNCT
iajs-3338	33	32	and	and	CCONJ
iajs-3338	33	33	type	type	NOUN
iajs-3338	33	34	1(interleukin	1(interleukin	NUM
iajs-3338	33	35	(	(	PUNCT
iajs-3338	33	36	il-2	il-2	NUM
iajs-3338	33	37	)	)	PUNCT
iajs-3338	33	38	,	,	PUNCT
iajs-3338	33	39	il-12	il-12	NOUN
iajs-3338	33	40	,	,	PUNCT
iajs-3338	33	41	interferon	interferon	NOUN
iajs-3338	33	42	(	(	PUNCT
iajs-3338	33	43	ifn	ifn	PROPN
iajs-3338	33	44	)	)	PUNCT
iajs-3338	33	45	,	,	PUNCT
iajs-3338	33	46	and	and	CCONJ
iajs-3338	33	47	tumor	tumor	NOUN
iajs-3338	33	48	necrosis	necrosis	NOUN
iajs-3338	33	49	factor	factor	NOUN
iajs-3338	33	50	(	(	PUNCT
iajs-3338	33	51	tnf	tnf	PROPN
iajs-3338	33	52	)	)	PUNCT
iajs-3338	33	53	,	,	PUNCT
iajs-3338	33	54	which	which	PRON
iajs-3338	33	55	enhance	enhance	VERB
iajs-3338	33	56	cellular	cellular	ADJ
iajs-3338	33	57	immunity	immunity	NOUN
iajs-3338	33	58	[	[	X
iajs-3338	33	59	21	21	NUM
iajs-3338	33	60	]	]	PUNCT
iajs-3338	33	61	.	.	PUNCT
iajs-3338	34	1	the	the	DET
iajs-3338	34	2	cytokine	cytokine	NOUN
iajs-3338	34	3	profile	profile	NOUN
iajs-3338	34	4	controls	control	VERB
iajs-3338	34	5	immune	immune	ADJ
iajs-3338	34	6	activation	activation	NOUN
iajs-3338	34	7	and	and	CCONJ
iajs-3338	34	8	tolerance	tolerance	NOUN
iajs-3338	34	9	[	[	X
iajs-3338	34	10	22	22	NUM
iajs-3338	34	11	]	]	PUNCT
iajs-3338	34	12	.	.	PUNCT
iajs-3338	35	1	il-2	il-2	PROPN
iajs-3338	35	2	is	be	AUX
iajs-3338	35	3	a	a	DET
iajs-3338	35	4	15	15	NUM
iajs-3338	35	5	-	-	PUNCT
iajs-3338	35	6	kda	kda	NOUN
iajs-3338	35	7	glycoprotein	glycoprotein	NOUN
iajs-3338	35	8	that	that	PRON
iajs-3338	35	9	was	be	AUX
iajs-3338	35	10	originally	originally	ADV
iajs-3338	35	11	referred	refer	VERB
iajs-3338	35	12	to	to	ADP
iajs-3338	35	13	as	as	ADP
iajs-3338	35	14	t	t	NOUN
iajs-3338	35	15	-	-	PUNCT
iajs-3338	35	16	cell	cell	NOUN
iajs-3338	35	17	growth	growth	NOUN
iajs-3338	35	18	factor	factor	NOUN
iajs-3338	35	19	(	(	PUNCT
iajs-3338	35	20	tcgf	tcgf	PROPN
iajs-3338	35	21	)	)	PUNCT
iajs-3338	35	22	.	.	PUNCT
iajs-3338	36	1	helper	helper	NOUN
iajs-3338	36	2	t	t	PROPN
iajs-3338	36	3	cells	cell	NOUN
iajs-3338	36	4	that	that	PRON
iajs-3338	36	5	have	have	AUX
iajs-3338	36	6	been	be	AUX
iajs-3338	36	7	activated	activate	VERB
iajs-3338	36	8	are	be	AUX
iajs-3338	36	9	the	the	DET
iajs-3338	36	10	main	main	ADJ
iajs-3338	36	11	sources	source	NOUN
iajs-3338	36	12	of	of	ADP
iajs-3338	36	13	il-2	il-2	NUM
iajs-3338	36	14	secretion	secretion	NOUN
iajs-3338	36	15	.	.	PUNCT
iajs-3338	37	1	for	for	ADP
iajs-3338	37	2	controlling	control	VERB
iajs-3338	37	3	cellular	cellular	ADJ
iajs-3338	37	4	and	and	CCONJ
iajs-3338	37	5	cellular	cellular	ADJ
iajs-3338	37	6	-	-	PUNCT
iajs-3338	37	7	chronic	chronic	ADJ
iajs-3338	37	8	inflammatory	inflammatory	ADJ
iajs-3338	37	9	responses	response	NOUN
iajs-3338	37	10	,	,	PUNCT
iajs-3338	37	11	it	it	PRON
iajs-3338	37	12	is	be	AUX
iajs-3338	37	13	essential	essential	ADJ
iajs-3338	37	14	.	.	PUNCT
iajs-3338	38	1	t	t	NOUN
iajs-3338	38	2	cells	cell	NOUN
iajs-3338	38	3	have	have	VERB
iajs-3338	38	4	an	an	DET
iajs-3338	38	5	il2	il2	NOUN
iajs-3338	38	6	receptor	receptor	NOUN
iajs-3338	38	7	that	that	PRON
iajs-3338	38	8	il-2	il-2	NOUN
iajs-3338	38	9	binds	bind	VERB
iajs-3338	38	10	to	to	PART
iajs-3338	38	11	,	,	PUNCT
iajs-3338	38	12	which	which	PRON
iajs-3338	38	13	causes	cause	VERB
iajs-3338	38	14	the	the	DET
iajs-3338	38	15	production	production	NOUN
iajs-3338	38	16	of	of	ADP
iajs-3338	38	17	lymphokines	lymphokine	NOUN
iajs-3338	38	18	and	and	CCONJ
iajs-3338	38	19	the	the	DET
iajs-3338	38	20	promotion	promotion	NOUN
iajs-3338	38	21	of	of	ADP
iajs-3338	38	22	cell	cell	NOUN
iajs-3338	38	23	proliferation	proliferation	NOUN
iajs-3338	38	24	[	[	X
iajs-3338	38	25	23	23	NUM
iajs-3338	38	26	,	,	PUNCT
iajs-3338	38	27	24	24	NUM
iajs-3338	38	28	]	]	PUNCT
iajs-3338	38	29	.	.	PUNCT
iajs-3338	39	1	natural	natural	ADJ
iajs-3338	39	2	killer	killer	NOUN
iajs-3338	39	3	cells	cell	NOUN
iajs-3338	39	4	,	,	PUNCT
iajs-3338	39	5	as	as	ADV
iajs-3338	39	6	well	well	ADV
iajs-3338	39	7	as	as	ADP
iajs-3338	39	8	antigen	antigen	ADV
iajs-3338	39	9	-	-	PUNCT
iajs-3338	39	10	presenting	present	VERB
iajs-3338	39	11	cells	cell	NOUN
iajs-3338	39	12	like	like	ADP
iajs-3338	39	13	dendritic	dendritic	ADJ
iajs-3338	39	14	cells	cell	NOUN
iajs-3338	39	15	(	(	PUNCT
iajs-3338	39	16	dcs	dcs	PROPN
iajs-3338	39	17	)	)	PUNCT
iajs-3338	39	18	and	and	CCONJ
iajs-3338	39	19	macrophages	macrophage	NOUN
iajs-3338	39	20	,	,	PUNCT
iajs-3338	39	21	produce	produce	VERB
iajs-3338	39	22	the	the	DET
iajs-3338	39	23	interleukin-12	interleukin-12	PROPN
iajs-3338	39	24	[	[	X
iajs-3338	39	25	25	25	NUM
iajs-3338	39	26	]	]	PUNCT
iajs-3338	39	27	.	.	PUNCT
iajs-3338	40	1	the	the	DET
iajs-3338	40	2	aim	aim	NOUN
iajs-3338	40	3	of	of	ADP
iajs-3338	40	4	this	this	DET
iajs-3338	40	5	study	study	NOUN
iajs-3338	40	6	was	be	AUX
iajs-3338	40	7	to	to	PART
iajs-3338	40	8	investigate	investigate	VERB
iajs-3338	40	9	the	the	DET
iajs-3338	40	10	concentration	concentration	NOUN
iajs-3338	40	11	of	of	ADP
iajs-3338	40	12	interleukin	interleukin	NOUN
iajs-3338	40	13	2	2	NUM
iajs-3338	40	14	(	(	PUNCT
iajs-3338	40	15	il-2	il-2	NUM
iajs-3338	40	16	)	)	PUNCT
iajs-3338	40	17	and	and	CCONJ
iajs-3338	40	18	interleukin	interleukin	NOUN
iajs-3338	40	19	12(il-12	12(il-12	NOUN
iajs-3338	40	20	)	)	PUNCT
iajs-3338	40	21	in	in	ADP
iajs-3338	40	22	saliva	saliva	NOUN
iajs-3338	40	23	of	of	ADP
iajs-3338	40	24	patients	patient	NOUN
iajs-3338	40	25	with	with	ADP
iajs-3338	40	26	ras	ras	PROPN
iajs-3338	40	27	.	.	PROPN
iajs-3338	40	28	2	2	NUM
iajs-3338	40	29	.	.	PUNCT
iajs-3338	40	30	materials	material	NOUN
iajs-3338	40	31	and	and	CCONJ
iajs-3338	40	32	methods	method	NOUN
iajs-3338	40	33	the	the	DET
iajs-3338	40	34	study	study	NOUN
iajs-3338	40	35	included	include	VERB
iajs-3338	40	36	40	40	NUM
iajs-3338	40	37	patients	patient	NOUN
iajs-3338	40	38	with	with	ADP
iajs-3338	40	39	ras	ras	PROPN
iajs-3338	40	40	ranged	range	VERB
iajs-3338	40	41	between	between	ADP
iajs-3338	40	42	(	(	PUNCT
iajs-3338	40	43	16	16	NUM
iajs-3338	40	44	-	-	SYM
iajs-3338	40	45	60	60	NUM
iajs-3338	40	46	)	)	PUNCT
iajs-3338	40	47	years	year	NOUN
iajs-3338	40	48	.	.	PUNCT
iajs-3338	40	49	,	,	PUNCT
iajs-3338	40	50	compared	compare	VERB
iajs-3338	40	51	with	with	ADP
iajs-3338	40	52	40	40	NUM
iajs-3338	40	53	apparently	apparently	ADV
iajs-3338	40	54	healthy	healthy	ADJ
iajs-3338	40	55	individuals	individual	NOUN
iajs-3338	40	56	ranged	range	VERB
iajs-3338	40	57	between	between	ADP
iajs-3338	40	58	(	(	PUNCT
iajs-3338	40	59	16	16	NUM
iajs-3338	40	60	-	-	PUNCT
iajs-3338	40	61	60years	60years	NUM
iajs-3338	40	62	)	)	PUNCT
iajs-3338	40	63	considered	consider	VERB
iajs-3338	40	64	as	as	ADP
iajs-3338	40	65	a	a	DET
iajs-3338	40	66	controls	control	NOUN
iajs-3338	40	67	.	.	PUNCT
iajs-3338	41	1	saliva	saliva	NOUN
iajs-3338	41	2	was	be	AUX
iajs-3338	41	3	collected	collect	VERB
iajs-3338	41	4	from	from	ADP
iajs-3338	41	5	patients	patient	NOUN
iajs-3338	41	6	and	and	CCONJ
iajs-3338	41	7	control	control	NOUN
iajs-3338	41	8	group	group	NOUN
iajs-3338	41	9	between	between	ADP
iajs-3338	41	10	9	9	NUM
iajs-3338	41	11	-	-	PUNCT
iajs-3338	41	12	12am	12am	NOUN
iajs-3338	41	13	to	to	PART
iajs-3338	41	14	evaluate	evaluate	VERB
iajs-3338	41	15	the	the	DET
iajs-3338	41	16	concentrations	concentration	NOUN
iajs-3338	41	17	of	of	ADP
iajs-3338	41	18	interleukin	interleukin	NOUN
iajs-3338	41	19	2	2	NUM
iajs-3338	41	20	(	(	PUNCT
iajs-3338	41	21	il-2	il-2	NUM
iajs-3338	41	22	)	)	PUNCT
iajs-3338	41	23	and	and	CCONJ
iajs-3338	41	24	il-12	il-12	NOUN
iajs-3338	41	25	in	in	ADP
iajs-3338	41	26	saliva	saliva	NOUN
iajs-3338	41	27	were	be	AUX
iajs-3338	41	28	measured	measure	VERB
iajs-3338	41	29	by	by	ADP
iajs-3338	41	30	enzyme	enzyme	NOUN
iajs-3338	41	31	-	-	PUNCT
iajs-3338	41	32	linked	link	VERB
iajs-3338	41	33	immunosorbent	immunosorbent	NOUN
iajs-3338	41	34	assay	assay	PROPN
iajs-3338	41	35	(	(	PUNCT
iajs-3338	41	36	elisa	elisa	NOUN
iajs-3338	41	37	)	)	PUNCT
iajs-3338	41	38	kit	kit	NOUN
iajs-3338	41	39	that	that	PRON
iajs-3338	41	40	is	be	AUX
iajs-3338	41	41	commercially	commercially	ADV
iajs-3338	41	42	available	available	ADJ
iajs-3338	41	43	.	.	PUNCT
iajs-3338	42	1	this	this	PRON
iajs-3338	42	2	was	be	AUX
iajs-3338	42	3	completed	complete	VERB
iajs-3338	42	4	in	in	ADP
iajs-3338	42	5	accordance	accordance	NOUN
iajs-3338	42	6	with	with	ADP
iajs-3338	42	7	the	the	DET
iajs-3338	42	8	booklet	booklet	NOUN
iajs-3338	42	9	of	of	ADP
iajs-3338	42	10	the	the	DET
iajs-3338	42	11	kit	kit	NOUN
iajs-3338	42	12	's	's	PART
iajs-3338	42	13	instructions	instruction	NOUN
iajs-3338	42	14	.	.	PUNCT
iajs-3338	43	1	interleukin	interleukin	NOUN
iajs-3338	43	2	12	12	NUM
iajs-3338	43	3	(	(	PUNCT
iajs-3338	43	4	il-12	il-12	NOUN
iajs-3338	43	5	)	)	PUNCT
iajs-3338	43	6	and	and	CCONJ
iajs-3338	43	7	il-2	il-2	PROPN
iajs-3338	43	8	elisa	elisa	PROPN
iajs-3338	43	9	kit	kit	NOUN
iajs-3338	43	10	for	for	ADP
iajs-3338	43	11	humans	human	NOUN
iajs-3338	43	12	(	(	PUNCT
iajs-3338	43	13	my	my	PRON
iajs-3338	43	14	biosource	biosource	NOUN
iajs-3338	43	15	,	,	PUNCT
iajs-3338	43	16	usa	usa	PROPN
iajs-3338	43	17	)	)	PUNCT
iajs-3338	43	18	.	.	PUNCT
iajs-3338	44	1	2.1	2.1	NUM
iajs-3338	44	2	.	.	PUNCT
iajs-3338	45	1	statistical	statistical	ADJ
iajs-3338	45	2	analysis	analysis	NOUN
iajs-3338	45	3	data	datum	NOUN
iajs-3338	45	4	description	description	NOUN
iajs-3338	45	5	,	,	PUNCT
iajs-3338	45	6	analysis	analysis	NOUN
iajs-3338	45	7	and	and	CCONJ
iajs-3338	45	8	presentation	presentation	NOUN
iajs-3338	45	9	have	have	AUX
iajs-3338	45	10	been	be	AUX
iajs-3338	45	11	performed	perform	VERB
iajs-3338	45	12	using	use	VERB
iajs-3338	45	13	computerized	computerized	ADJ
iajs-3338	45	14	software	software	NOUN
iajs-3338	45	15	statistical	statistical	ADJ
iajs-3338	45	16	package	package	NOUN
iajs-3338	45	17	for	for	ADP
iajs-3338	45	18	social	social	ADJ
iajs-3338	45	19	science	science	NOUN
iajs-3338	45	20	(	(	PUNCT
iajs-3338	45	21	spss	spss	PROPN
iajs-3338	45	22	version-22	version-22	PROPN
iajs-3338	45	23	)	)	PUNCT
iajs-3338	45	24	.	.	PUNCT
iajs-3338	46	1	shapiro	shapiro	PROPN
iajs-3338	46	2	wilk	wilk	PROPN
iajs-3338	46	3	test	test	PROPN
iajs-3338	46	4	was	be	AUX
iajs-3338	46	5	used	use	VERB
iajs-3338	46	6	to	to	PART
iajs-3338	46	7	test	test	VERB
iajs-3338	46	8	the	the	DET
iajs-3338	46	9	normality	normality	NOUN
iajs-3338	46	10	distribution	distribution	NOUN
iajs-3338	46	11	of	of	ADP
iajs-3338	46	12	the	the	DET
iajs-3338	46	13	quantitative	quantitative	ADJ
iajs-3338	46	14	variable	variable	NOUN
iajs-3338	46	15	.	.	PUNCT
iajs-3338	47	1	both	both	DET
iajs-3338	47	2	descriptive	descriptive	ADJ
iajs-3338	47	3	and	and	CCONJ
iajs-3338	47	4	inferential	inferential	ADJ
iajs-3338	47	5	statistics	statistic	NOUN
iajs-3338	47	6	were	be	AUX
iajs-3338	47	7	used	use	VERB
iajs-3338	47	8	[	[	PUNCT
iajs-3338	47	9	26	26	NUM
iajs-3338	47	10	]	]	PUNCT
iajs-3338	47	11	.	.	PUNCT
iajs-3338	48	1	the	the	DET
iajs-3338	48	2	descriptive	descriptive	ADJ
iajs-3338	48	3	statistics	statistic	NOUN
iajs-3338	48	4	included	include	VERB
iajs-3338	48	5	:	:	PUNCT
iajs-3338	48	6	frequency	frequency	NOUN
iajs-3338	48	7	,	,	PUNCT
iajs-3338	48	8	percentage	percentage	NOUN
iajs-3338	48	9	,	,	PUNCT
iajs-3338	48	10	minimum	minimum	ADJ
iajs-3338	48	11	,	,	PUNCT
iajs-3338	48	12	maximum	maximum	ADJ
iajs-3338	48	13	,	,	PUNCT
iajs-3338	48	14	mean	mean	ADJ
iajs-3338	48	15	,	,	PUNCT
iajs-3338	48	16	standard	standard	ADJ
iajs-3338	48	17	deviation	deviation	NOUN
iajs-3338	48	18	(	(	PUNCT
iajs-3338	48	19	sd	sd	NOUN
iajs-3338	48	20	)	)	PUNCT
iajs-3338	48	21	and	and	CCONJ
iajs-3338	48	22	graphical	graphical	ADJ
iajs-3338	48	23	presentation	presentation	NOUN
iajs-3338	48	24	by	by	ADP
iajs-3338	48	25	bar	bar	NOUN
iajs-3338	48	26	charts	chart	NOUN
iajs-3338	48	27	.	.	PUNCT
iajs-3338	49	1	inferential	inferential	ADJ
iajs-3338	49	2	statistics	statistic	NOUN
iajs-3338	49	3	were	be	AUX
iajs-3338	49	4	used	use	VERB
iajs-3338	49	5	to	to	PART
iajs-3338	49	6	accept	accept	VERB
iajs-3338	49	7	or	or	CCONJ
iajs-3338	49	8	reject	reject	VERB
iajs-3338	49	9	the	the	DET
iajs-3338	49	10	statistical	statistical	ADJ
iajs-3338	49	11	hypotheses	hypothesis	NOUN
iajs-3338	49	12	which	which	PRON
iajs-3338	49	13	included	include	VERB
iajs-3338	49	14	:	:	PUNCT
iajs-3338	49	15	analysis	analysis	NOUN
iajs-3338	49	16	of	of	ADP
iajs-3338	49	17	variance	variance	NOUN
iajs-3338	49	18	student	student	NOUN
iajs-3338	49	19	t	t	PROPN
iajs-3338	49	20	-	-	PUNCT
iajs-3338	49	21	test	test	NOUN
iajs-3338	49	22	and	and	CCONJ
iajs-3338	49	23	chi	chi	ADJ
iajs-3338	49	24	-	-	PUNCT
iajs-3338	49	25	square	square	ADJ
iajs-3338	49	26	test	test	NOUN
iajs-3338	49	27	.	.	PUNCT
iajs-3338	50	1	the	the	DET
iajs-3338	50	2	statistical	statistical	ADJ
iajs-3338	50	3	significance	significance	NOUN
iajs-3338	50	4	of	of	ADP
iajs-3338	50	5	difference	difference	NOUN
iajs-3338	50	6	of	of	ADP
iajs-3338	50	7	mean	mean	NOUN
iajs-3338	50	8	between	between	ADP
iajs-3338	50	9	2	2	NUM
iajs-3338	50	10	groups	group	NOUN
iajs-3338	50	11	was	be	AUX
iajs-3338	50	12	calculated	calculate	VERB
iajs-3338	50	13	by	by	ADP
iajs-3338	50	14	t	t	PROPN
iajs-3338	50	15	-	-	PUNCT
iajs-3338	50	16	test	test	NOUN
iajs-3338	50	17	and	and	CCONJ
iajs-3338	50	18	chi	chi	ADJ
iajs-3338	50	19	-	-	PUNCT
iajs-3338	50	20	square	square	ADJ
iajs-3338	50	21	test	test	NOUN
iajs-3338	50	22	.	.	PUNCT
iajs-3338	51	1	correlation	correlation	NOUN
iajs-3338	51	2	among	among	ADP
iajs-3338	51	3	different	different	ADJ
iajs-3338	51	4	parameters	parameter	NOUN
iajs-3338	51	5	was	be	AUX
iajs-3338	51	6	calculated	calculate	VERB
iajs-3338	51	7	by	by	ADP
iajs-3338	51	8	the	the	DET
iajs-3338	51	9	pearson	pearson	PROPN
iajs-3338	51	10	correlation	correlation	PROPN
iajs-3338	51	11	coefficient	coefficient	NOUN
iajs-3338	51	12	test	test	NOUN
iajs-3338	51	13	.	.	PUNCT
iajs-3338	52	1	in	in	ADP
iajs-3338	52	2	the	the	DET
iajs-3338	52	3	statistical	statistical	ADJ
iajs-3338	52	4	evaluation	evaluation	NOUN
iajs-3338	52	5	,	,	PUNCT
iajs-3338	52	6	the	the	DET
iajs-3338	52	7	following	follow	VERB
iajs-3338	52	8	levels	level	NOUN
iajs-3338	52	9	of	of	ADP
iajs-3338	52	10	significance	significance	NOUN
iajs-3338	52	11	are	be	AUX
iajs-3338	52	12	used	use	VERB
iajs-3338	52	13	:	:	PUNCT
iajs-3338	52	14	not	not	PART
iajs-3338	52	15	significant	significant	ADJ
iajs-3338	52	16	p>0.05	p>0.05	NOUN
iajs-3338	52	17	,	,	PUNCT
iajs-3338	52	18	significant	significant	ADJ
iajs-3338	52	19	p≤0.05	p≤0.05	NOUN
iajs-3338	52	20	,	,	PUNCT
iajs-3338	52	21	highly	highly	ADV
iajs-3338	52	22	significant	significant	ADJ
iajs-3338	52	23	p≤0.01	p≤0.01	NOUN
iajs-3338	52	24	.	.	PUNCT
iajs-3338	53	1	ihjpas	ihjpas	PROPN
iajs-3338	53	2	.	.	PUNCT
iajs-3338	54	1	2024	2024	NUM
iajs-3338	54	2	,	,	PUNCT
iajs-3338	54	3	37(4	37(4	NOUN
iajs-3338	54	4	)	)	PUNCT
iajs-3338	54	5	21	21	NUM
iajs-3338	54	6	3	3	NUM
iajs-3338	54	7	.	.	PUNCT
iajs-3338	54	8	results	result	VERB
iajs-3338	54	9	3.1	3.1	NUM
iajs-3338	54	10	.	.	PUNCT
iajs-3338	55	1	the	the	DET
iajs-3338	55	2	concentration	concentration	NOUN
iajs-3338	55	3	of	of	ADP
iajs-3338	55	4	il-2	il-2	NUM
iajs-3338	55	5	in	in	ADP
iajs-3338	55	6	saliva	saliva	NOUN
iajs-3338	55	7	the	the	DET
iajs-3338	55	8	results	result	NOUN
iajs-3338	55	9	of	of	ADP
iajs-3338	55	10	this	this	DET
iajs-3338	55	11	study	study	NOUN
iajs-3338	55	12	showed	show	VERB
iajs-3338	55	13	,	,	PUNCT
iajs-3338	55	14	there	there	PRON
iajs-3338	55	15	is	be	VERB
iajs-3338	55	16	elevation	elevation	NOUN
iajs-3338	55	17	in	in	ADP
iajs-3338	55	18	the	the	DET
iajs-3338	55	19	concentration	concentration	NOUN
iajs-3338	55	20	of	of	ADP
iajs-3338	55	21	il-2	il-2	NUM
iajs-3338	55	22	in	in	ADP
iajs-3338	55	23	saliva	saliva	NOUN
iajs-3338	55	24	of	of	ADP
iajs-3338	55	25	patients	patient	NOUN
iajs-3338	55	26	with	with	ADP
iajs-3338	55	27	(	(	PUNCT
iajs-3338	55	28	ras)(159.06	ras)(159.06	NOUN
iajs-3338	55	29	)	)	PUNCT
iajs-3338	55	30	comparing	compare	VERB
iajs-3338	55	31	with	with	ADP
iajs-3338	55	32	it	it	PRON
iajs-3338	55	33	is	be	AUX
iajs-3338	55	34	concentration	concentration	NOUN
iajs-3338	55	35	in	in	ADP
iajs-3338	55	36	saliva	saliva	NOUN
iajs-3338	55	37	of	of	ADP
iajs-3338	55	38	control	control	NOUN
iajs-3338	55	39	group	group	NOUN
iajs-3338	55	40	(	(	PUNCT
iajs-3338	55	41	table	table	NOUN
iajs-3338	55	42	1	1	NUM
iajs-3338	55	43	)	)	PUNCT
iajs-3338	55	44	,	,	PUNCT
iajs-3338	55	45	(	(	PUNCT
iajs-3338	55	46	figure	figure	NOUN
iajs-3338	55	47	1	1	NUM
iajs-3338	55	48	)	)	PUNCT
iajs-3338	55	49	.	.	PUNCT
iajs-3338	56	1	table	table	NOUN
iajs-3338	56	2	1	1	NUM
iajs-3338	56	3	.	.	PUNCT
iajs-3338	56	4	descriptive	descriptive	ADJ
iajs-3338	56	5	and	and	CCONJ
iajs-3338	56	6	analytic	analytic	ADJ
iajs-3338	56	7	statistics	statistic	NOUN
iajs-3338	56	8	of	of	ADP
iajs-3338	56	9	mean	mean	PROPN
iajs-3338	56	10	±sd	±sd	PRON
iajs-3338	56	11	il-2	il-2	ADJ
iajs-3338	56	12	concentration	concentration	NOUN
iajs-3338	56	13	level	level	NOUN
iajs-3338	56	14	for	for	ADP
iajs-3338	56	15	patients	patient	NOUN
iajs-3338	56	16	and	and	CCONJ
iajs-3338	56	17	control	control	NOUN
iajs-3338	56	18	.	.	PUNCT
iajs-3338	57	1	il-2	il-2	PROPN
iajs-3338	57	2	pg	pg	PROPN
iajs-3338	57	3	/	/	SYM
iajs-3338	57	4	ml	ml	PROPN
iajs-3338	57	5	group	group	NOUN
iajs-3338	57	6	of	of	ADP
iajs-3338	57	7	the	the	DET
iajs-3338	57	8	patients	patient	NOUN
iajs-3338	57	9	n=40	n=40	ADJ
iajs-3338	57	10	group	group	NOUN
iajs-3338	57	11	of	of	ADP
iajs-3338	57	12	the	the	DET
iajs-3338	57	13	control	control	PROPN
iajs-3338	57	14	n=40	n=40	PROPN
iajs-3338	57	15	t	t	PROPN
iajs-3338	57	16	-	-	PUNCT
iajs-3338	57	17	test	test	NOUN
iajs-3338	57	18	(	(	PUNCT
iajs-3338	57	19	p.value	p.value	NOUN
iajs-3338	57	20	)	)	PUNCT
iajs-3338	57	21	‘	'	PUNCT
iajs-3338	57	22	minimum	minimum	ADJ
iajs-3338	57	23	’	'	PUNCT
iajs-3338	57	24	125.84	125.84	NUM
iajs-3338	57	25	65.66	65.66	NUM
iajs-3338	57	26	0.000	0.000	NUM
iajs-3338	57	27	*	*	PUNCT
iajs-3338	57	28	*	*	PUNCT
iajs-3338	57	29	‘	'	PUNCT
iajs-3338	57	30	maximum	maximum	ADJ
iajs-3338	57	31	’	'	PUNCT
iajs-3338	57	32	236.21	236.21	NUM
iajs-3338	57	33	98.95	98.95	NUM
iajs-3338	57	34	mean	mean	NOUN
iajs-3338	57	35	159.06	159.06	NUM
iajs-3338	57	36	82.09	82.09	NUM
iajs-3338	57	37	sd	sd	ADP
iajs-3338	57	38	20.37	20.37	NUM
iajs-3338	57	39	8.35	8.35	NUM
iajs-3338	57	40	se	se	X
iajs-3338	57	41	3.22	3.22	NUM
iajs-3338	57	42	1.32	1.32	NUM
iajs-3338	57	43	figure	figure	NOUN
iajs-3338	57	44	1	1	NUM
iajs-3338	57	45	.	.	PUNCT
iajs-3338	57	46	descriptive	descriptive	ADJ
iajs-3338	57	47	and	and	CCONJ
iajs-3338	57	48	analytic	analytic	ADJ
iajs-3338	57	49	statistics	statistic	NOUN
iajs-3338	57	50	of	of	ADP
iajs-3338	57	51	mean	mean	ADJ
iajs-3338	57	52	value	value	NOUN
iajs-3338	57	53	of	of	ADP
iajs-3338	57	54	il-2	il-2	ADJ
iajs-3338	57	55	concentration	concentration	NOUN
iajs-3338	57	56	for	for	ADP
iajs-3338	57	57	patients	patient	NOUN
iajs-3338	57	58	and	and	CCONJ
iajs-3338	57	59	control	control	NOUN
iajs-3338	57	60	.	.	PUNCT
iajs-3338	58	1	3.2	3.2	NUM
iajs-3338	58	2	.	.	PUNCT
iajs-3338	59	1	the	the	DET
iajs-3338	59	2	concentration	concentration	NOUN
iajs-3338	59	3	of	of	ADP
iajs-3338	59	4	il-12	il-12	NOUN
iajs-3338	59	5	in	in	ADP
iajs-3338	59	6	saliva	saliva	NOUN
iajs-3338	59	7	the	the	DET
iajs-3338	59	8	results	result	NOUN
iajs-3338	59	9	of	of	ADP
iajs-3338	59	10	this	this	DET
iajs-3338	59	11	study	study	NOUN
iajs-3338	59	12	showed	show	VERB
iajs-3338	59	13	,	,	PUNCT
iajs-3338	59	14	there	there	PRON
iajs-3338	59	15	is	be	VERB
iajs-3338	59	16	elevation	elevation	NOUN
iajs-3338	59	17	in	in	ADP
iajs-3338	59	18	the	the	DET
iajs-3338	59	19	concentration	concentration	NOUN
iajs-3338	59	20	of	of	ADP
iajs-3338	59	21	il-12	il-12	NOUN
iajs-3338	59	22	in	in	ADP
iajs-3338	59	23	saliva	saliva	NOUN
iajs-3338	59	24	of	of	ADP
iajs-3338	59	25	patients	patient	NOUN
iajs-3338	59	26	with	with	ADP
iajs-3338	59	27	(	(	PUNCT
iajs-3338	59	28	ras)(331.32	ras)(331.32	NOUN
iajs-3338	59	29	)	)	PUNCT
iajs-3338	59	30	comparing	compare	VERB
iajs-3338	59	31	with	with	ADP
iajs-3338	59	32	it	it	PRON
iajs-3338	59	33	is	be	AUX
iajs-3338	59	34	concentration	concentration	NOUN
iajs-3338	59	35	in	in	ADP
iajs-3338	59	36	saliva	saliva	NOUN
iajs-3338	59	37	of	of	ADP
iajs-3338	59	38	control	control	NOUN
iajs-3338	59	39	group	group	NOUN
iajs-3338	59	40	(	(	PUNCT
iajs-3338	59	41	table	table	NOUN
iajs-3338	59	42	2	2	NUM
iajs-3338	59	43	)	)	PUNCT
iajs-3338	59	44	,	,	PUNCT
iajs-3338	59	45	(	(	PUNCT
iajs-3338	59	46	figure	figure	NOUN
iajs-3338	59	47	2	2	NUM
iajs-3338	59	48	)	)	PUNCT
iajs-3338	59	49	.	.	PUNCT
iajs-3338	60	1	table	table	NOUN
iajs-3338	60	2	2	2	NUM
iajs-3338	60	3	.	.	PUNCT
iajs-3338	60	4	descriptive	descriptive	ADJ
iajs-3338	60	5	and	and	CCONJ
iajs-3338	60	6	analytic	analytic	ADJ
iajs-3338	60	7	statistics	statistic	NOUN
iajs-3338	60	8	of	of	ADP
iajs-3338	60	9	mean	mean	ADJ
iajs-3338	60	10	±sd	±sd	NOUN
iajs-3338	60	11	il-12	il-12	NOUN
iajs-3338	60	12	concentration	concentration	NOUN
iajs-3338	60	13	for	for	ADP
iajs-3338	60	14	patients	patient	NOUN
iajs-3338	60	15	and	and	CCONJ
iajs-3338	60	16	control	control	NOUN
iajs-3338	60	17	.	.	PUNCT
iajs-3338	61	1	il-12	il-12	DET
iajs-3338	61	2	pg	pg	PROPN
iajs-3338	61	3	/	/	SYM
iajs-3338	61	4	ml	ml	NOUN
iajs-3338	61	5	group	group	NOUN
iajs-3338	61	6	of	of	ADP
iajs-3338	61	7	the	the	DET
iajs-3338	61	8	patients	patient	NOUN
iajs-3338	61	9	n=40	n=40	ADJ
iajs-3338	61	10	group	group	NOUN
iajs-3338	61	11	of	of	ADP
iajs-3338	61	12	the	the	DET
iajs-3338	61	13	control	control	PROPN
iajs-3338	61	14	n=40	n=40	PROPN
iajs-3338	61	15	t	t	PROPN
iajs-3338	61	16	-	-	PUNCT
iajs-3338	61	17	test	test	NOUN
iajs-3338	61	18	(	(	PUNCT
iajs-3338	61	19	p.value	p.value	NOUN
iajs-3338	61	20	)	)	PUNCT
iajs-3338	61	21	minimum	minimum	NOUN
iajs-3338	61	22	228.93	228.93	NUM
iajs-3338	61	23	79.29	79.29	NUM
iajs-3338	61	24	0.000	0.000	NUM
iajs-3338	61	25	*	*	PUNCT
iajs-3338	61	26	*	*	PUNCT
iajs-3338	61	27	maximum	maximum	PROPN
iajs-3338	61	28	811.55	811.55	NUM
iajs-3338	61	29	199.98	199.98	NUM
iajs-3338	61	30	mean	mean	NOUN
iajs-3338	61	31	331.32	331.32	NUM
iajs-3338	61	32	130.31	130.31	NUM
iajs-3338	61	33	sd	sd	ADP
iajs-3338	61	34	94.42	94.42	NUM
iajs-3338	61	35	34.38	34.38	NUM
iajs-3338	61	36	se	se	PROPN
iajs-3338	61	37	14.93	14.93	NUM
iajs-3338	61	38	5.43	5.43	NUM
iajs-3338	61	39	patients	patient	NOUN
iajs-3338	61	40	control	control	VERB
iajs-3338	61	41	il-2	il-2	NUM
iajs-3338	61	42	159.06	159.06	NUM
iajs-3338	61	43	82.09	82.09	NUM
iajs-3338	61	44	0	0	NUM
iajs-3338	61	45	20	20	NUM
iajs-3338	61	46	40	40	NUM
iajs-3338	61	47	60	60	NUM
iajs-3338	61	48	80	80	NUM
iajs-3338	61	49	100	100	NUM
iajs-3338	61	50	120	120	NUM
iajs-3338	61	51	140	140	NUM
iajs-3338	61	52	160	160	NUM
iajs-3338	61	53	180	180	NUM
iajs-3338	61	54	m	m	VERB
iajs-3338	61	55	e	e	NOUN
iajs-3338	61	56	a	a	DET
iajs-3338	61	57	n	n	NOUN
iajs-3338	61	58	v	v	NOUN
iajs-3338	61	59	a	a	DET
iajs-3338	61	60	lu	lu	NOUN
iajs-3338	61	61	e	e	NOUN
iajs-3338	61	62	il-2	il-2	PROPN
iajs-3338	61	63	pg\ml	pg\ml	PROPN
iajs-3338	61	64	ihjpas	ihjpa	VERB
iajs-3338	61	65	.	.	PUNCT
iajs-3338	62	1	2024	2024	NUM
iajs-3338	62	2	,	,	PUNCT
iajs-3338	62	3	37(4	37(4	NOUN
iajs-3338	62	4	)	)	PUNCT
iajs-3338	62	5	22	22	NUM
iajs-3338	62	6	figure	figure	NOUN
iajs-3338	62	7	2	2	NUM
iajs-3338	62	8	.	.	PUNCT
iajs-3338	62	9	effect	effect	NOUN
iajs-3338	62	10	of	of	ADP
iajs-3338	62	11	age	age	NOUN
iajs-3338	62	12	groups	group	NOUN
iajs-3338	62	13	in	in	ADP
iajs-3338	62	14	parameters	parameter	NOUN
iajs-3338	62	15	of	of	ADP
iajs-3338	62	16	sample	sample	NOUN
iajs-3338	62	17	studied	study	VERB
iajs-3338	62	18	.	.	PUNCT
iajs-3338	63	1	4	4	X
iajs-3338	63	2	.	.	X
iajs-3338	63	3	discussion	discussion	NOUN
iajs-3338	63	4	4.1	4.1	NUM
iajs-3338	63	5	.	.	PUNCT
iajs-3338	64	1	the	the	DET
iajs-3338	64	2	concentration	concentration	NOUN
iajs-3338	64	3	of	of	ADP
iajs-3338	64	4	il-2	il-2	NUM
iajs-3338	64	5	and	and	CCONJ
iajs-3338	64	6	il-12	il-12	NOUN
iajs-3338	64	7	in	in	ADP
iajs-3338	64	8	saliva	saliva	NOUN
iajs-3338	64	9	in	in	ADP
iajs-3338	64	10	this	this	DET
iajs-3338	64	11	study	study	NOUN
iajs-3338	64	12	,	,	PUNCT
iajs-3338	64	13	the	the	DET
iajs-3338	64	14	patient	patient	ADJ
iajs-3338	64	15	group	group	NOUN
iajs-3338	64	16	had	have	VERB
iajs-3338	64	17	significantly	significantly	ADV
iajs-3338	64	18	greater	great	ADJ
iajs-3338	64	19	concentrations	concentration	NOUN
iajs-3338	64	20	of	of	ADP
iajs-3338	64	21	il-2	il-2	NUM
iajs-3338	64	22	and	and	CCONJ
iajs-3338	64	23	il-12	il-12	NOUN
iajs-3338	64	24	in	in	ADP
iajs-3338	64	25	saliva	saliva	NOUN
iajs-3338	64	26	than	than	ADP
iajs-3338	64	27	the	the	DET
iajs-3338	64	28	control	control	NOUN
iajs-3338	64	29	group	group	NOUN
iajs-3338	64	30	.	.	PUNCT
iajs-3338	65	1	this	this	PRON
iajs-3338	65	2	is	be	AUX
iajs-3338	65	3	essential	essential	ADJ
iajs-3338	65	4	because	because	SCONJ
iajs-3338	65	5	ras	ras	NOUN
iajs-3338	65	6	frequently	frequently	ADV
iajs-3338	65	7	affects	affect	VERB
iajs-3338	65	8	the	the	DET
iajs-3338	65	9	oral	oral	ADJ
iajs-3338	65	10	mucosa	mucosa	NOUN
iajs-3338	65	11	and	and	CCONJ
iajs-3338	65	12	is	be	AUX
iajs-3338	65	13	caused	cause	VERB
iajs-3338	65	14	by	by	ADP
iajs-3338	65	15	alterations	alteration	NOUN
iajs-3338	65	16	in	in	ADP
iajs-3338	65	17	cellular	cellular	ADJ
iajs-3338	65	18	and	and	CCONJ
iajs-3338	65	19	humoral	humoral	ADJ
iajs-3338	65	20	immunity	immunity	NOUN
iajs-3338	65	21	.	.	PUNCT
iajs-3338	66	1	these	these	DET
iajs-3338	66	2	results	result	NOUN
iajs-3338	66	3	are	be	AUX
iajs-3338	66	4	in	in	ADP
iajs-3338	66	5	accordance	accordance	NOUN
iajs-3338	66	6	with	with	ADP
iajs-3338	66	7	other	other	ADJ
iajs-3338	66	8	results	result	NOUN
iajs-3338	66	9	the	the	DET
iajs-3338	66	10	level	level	NOUN
iajs-3338	66	11	of	of	ADP
iajs-3338	66	12	il-2	il-2	NUM
iajs-3338	66	13	and	and	CCONJ
iajs-3338	66	14	il-12	il-12	NOUN
iajs-3338	66	15	is	be	AUX
iajs-3338	66	16	highly	highly	ADV
iajs-3338	66	17	increased	increase	VERB
iajs-3338	66	18	while	while	SCONJ
iajs-3338	66	19	il-10	il-10	PRON
iajs-3338	66	20	is	be	AUX
iajs-3338	66	21	decreased	decrease	VERB
iajs-3338	66	22	in	in	ADP
iajs-3338	66	23	patients	patient	NOUN
iajs-3338	66	24	.	.	PUNCT
iajs-3338	67	1	the	the	DET
iajs-3338	67	2	age	age	NOUN
iajs-3338	67	3	group	group	NOUN
iajs-3338	67	4	20	20	NUM
iajs-3338	67	5	to	to	PART
iajs-3338	67	6	40	40	NUM
iajs-3338	67	7	years	year	NOUN
iajs-3338	67	8	showed	show	VERB
iajs-3338	67	9	a	a	DET
iajs-3338	67	10	higher	high	ADJ
iajs-3338	67	11	prevalence	prevalence	NOUN
iajs-3338	67	12	[	[	X
iajs-3338	67	13	27	27	NUM
iajs-3338	67	14	]	]	PUNCT
iajs-3338	67	15	.	.	PUNCT
iajs-3338	68	1	these	these	DET
iajs-3338	68	2	observations	observation	NOUN
iajs-3338	68	3	may	may	AUX
iajs-3338	68	4	be	be	AUX
iajs-3338	68	5	explained	explain	VERB
iajs-3338	68	6	by	by	ADP
iajs-3338	68	7	the	the	DET
iajs-3338	68	8	fact	fact	NOUN
iajs-3338	68	9	that	that	SCONJ
iajs-3338	68	10	the	the	DET
iajs-3338	68	11	pathogenesis	pathogenesis	NOUN
iajs-3338	68	12	of	of	ADP
iajs-3338	68	13	ras	ras	PROPN
iajs-3338	68	14	involves	involve	VERB
iajs-3338	68	15	cell	cell	NOUN
iajs-3338	68	16	-	-	PUNCT
iajs-3338	68	17	mediated	mediate	VERB
iajs-3338	68	18	responses	response	NOUN
iajs-3338	68	19	,	,	PUNCT
iajs-3338	68	20	involving	involve	VERB
iajs-3338	68	21	t	t	NOUN
iajs-3338	68	22	cells	cell	NOUN
iajs-3338	68	23	and	and	CCONJ
iajs-3338	68	24	tumor	tumor	NOUN
iajs-3338	68	25	necrosis	necrosis	NOUN
iajs-3338	68	26	factor	factor	NOUN
iajs-3338	68	27	(	(	PUNCT
iajs-3338	68	28	tnf)-α	tnf)-α	NOUN
iajs-3338	68	29	production	production	NOUN
iajs-3338	68	30	by	by	ADP
iajs-3338	68	31	these	these	DET
iajs-3338	68	32	and	and	CCONJ
iajs-3338	68	33	other	other	ADJ
iajs-3338	68	34	leucocytes	leucocyte	NOUN
iajs-3338	68	35	.	.	PUNCT
iajs-3338	69	1	tnf	tnf	PROPN
iajs-3338	69	2	is	be	AUX
iajs-3338	69	3	a	a	DET
iajs-3338	69	4	proinflammatory	proinflammatory	ADJ
iajs-3338	69	5	cytokine	cytokine	NOUN
iajs-3338	69	6	.secreted	.secrete	VERB
iajs-3338	69	7	by	by	ADP
iajs-3338	69	8	activated	activate	VERB
iajs-3338	69	9	monocytes	monocyte	NOUN
iajs-3338	69	10	,	,	PUNCT
iajs-3338	69	11	causing	cause	VERB
iajs-3338	69	12	activation	activation	NOUN
iajs-3338	69	13	of	of	ADP
iajs-3338	69	14	cytotoxic	cytotoxic	ADJ
iajs-3338	69	15	t	t	NOUN
iajs-3338	69	16	lymphocytes	lymphocyte	NOUN
iajs-3338	69	17	and	and	CCONJ
iajs-3338	69	18	neutrophils	neutrophil	NOUN
iajs-3338	69	19	;	;	PUNCT
iajs-3338	69	20	epithelial	epithelial	ADJ
iajs-3338	69	21	necrosis	necrosis	NOUN
iajs-3338	69	22	and	and	CCONJ
iajs-3338	69	23	eventually	eventually	ADV
iajs-3338	69	24	the	the	DET
iajs-3338	69	25	development	development	NOUN
iajs-3338	69	26	of	of	ADP
iajs-3338	69	27	an	an	DET
iajs-3338	69	28	aphthous	aphthous	ADJ
iajs-3338	69	29	lesion	lesion	NOUN
iajs-3338	69	30	[	[	X
iajs-3338	69	31	28	28	NUM
iajs-3338	69	32	]	]	PUNCT
iajs-3338	69	33	.	.	PUNCT
iajs-3338	70	1	this	this	DET
iajs-3338	70	2	study	study	NOUN
iajs-3338	70	3	may	may	AUX
iajs-3338	70	4	also	also	ADV
iajs-3338	70	5	be	be	AUX
iajs-3338	70	6	explained	explain	VERB
iajs-3338	70	7	by	by	ADP
iajs-3338	70	8	the	the	DET
iajs-3338	70	9	fact	fact	NOUN
iajs-3338	70	10	that	that	SCONJ
iajs-3338	70	11	type-1	type-1	NUM
iajs-3338	70	12	th1	th1	NOUN
iajs-3338	70	13	cytokines	cytokine	NOUN
iajs-3338	70	14	include	include	VERB
iajs-3338	70	15	proinflammatory	proinflammatory	ADJ
iajs-3338	70	16	cytokines	cytokine	NOUN
iajs-3338	70	17	like	like	ADP
iajs-3338	70	18	il-2	il-2	NOUN
iajs-3338	70	19	,	,	PUNCT
iajs-3338	70	20	il-12	il-12	NOUN
iajs-3338	70	21	,	,	PUNCT
iajs-3338	70	22	ifn	ifn	NOUN
iajs-3338	70	23	,	,	PUNCT
iajs-3338	70	24	and	and	CCONJ
iajs-3338	70	25	tnf	tnf	PROPN
iajs-3338	70	26	,	,	PUNCT
iajs-3338	70	27	wihich	wihich	PRON
iajs-3338	70	28	activate	activate	VERB
iajs-3338	70	29	cell	cell	NOUN
iajs-3338	70	30	-	-	PUNCT
iajs-3338	70	31	mediated	mediate	VERB
iajs-3338	70	32	immunity	immunity	NOUN
iajs-3338	70	33	[	[	X
iajs-3338	70	34	19	19	NUM
iajs-3338	70	35	]	]	PUNCT
iajs-3338	70	36	.	.	PUNCT
iajs-3338	71	1	significant	significant	ADJ
iajs-3338	71	2	elevation	elevation	NOUN
iajs-3338	71	3	in	in	ADP
iajs-3338	71	4	secretion	secretion	NOUN
iajs-3338	71	5	of	of	ADP
iajs-3338	71	6	th1	th1	NOUN
iajs-3338	71	7	cytokine	cytokine	NOUN
iajs-3338	71	8	that	that	PRON
iajs-3338	71	9	produces	produce	VERB
iajs-3338	71	10	pro	pro	ADJ
iajs-3338	71	11	-	-	ADJ
iajs-3338	71	12	inflammatory	inflammatory	ADJ
iajs-3338	71	13	cytokines	cytokine	NOUN
iajs-3338	71	14	(	(	PUNCT
iajs-3338	71	15	il-2	il-2	NUM
iajs-3338	71	16	,	,	PUNCT
iajs-3338	71	17	il-12	il-12	NOUN
iajs-3338	71	18	and	and	CCONJ
iajs-3338	71	19	ifn	ifn	PROPN
iajs-3338	71	20	-	-	PUNCT
iajs-3338	71	21	y	y	NOUN
iajs-3338	71	22	)	)	PUNCT
iajs-3338	71	23	increased	increase	VERB
iajs-3338	71	24	in	in	ADP
iajs-3338	71	25	patients	patient	NOUN
iajs-3338	71	26	with	with	ADP
iajs-3338	71	27	ras	ras	PROPN
iajs-3338	71	28	in	in	SCONJ
iajs-3338	71	29	comparison	comparison	NOUN
iajs-3338	71	30	to	to	ADP
iajs-3338	71	31	healthy	healthy	ADJ
iajs-3338	71	32	patients	patient	NOUN
iajs-3338	71	33	was	be	AUX
iajs-3338	71	34	demonstrated	demonstrate	VERB
iajs-3338	71	35	in	in	ADP
iajs-3338	71	36	earlier	early	ADJ
iajs-3338	71	37	studies	study	NOUN
iajs-3338	71	38	[	[	X
iajs-3338	71	39	29	29	NUM
iajs-3338	71	40	,	,	PUNCT
iajs-3338	71	41	30	30	NUM
iajs-3338	71	42	]	]	PUNCT
iajs-3338	71	43	.	.	PUNCT
iajs-3338	72	1	5	5	X
iajs-3338	72	2	.	.	PUNCT
iajs-3338	72	3	conclusions	conclusion	NOUN
iajs-3338	72	4	according	accord	VERB
iajs-3338	72	5	to	to	ADP
iajs-3338	72	6	these	these	DET
iajs-3338	72	7	results	result	NOUN
iajs-3338	72	8	,	,	PUNCT
iajs-3338	72	9	saliva	saliva	NOUN
iajs-3338	72	10	is	be	AUX
iajs-3338	72	11	the	the	DET
iajs-3338	72	12	optimal	optimal	ADJ
iajs-3338	72	13	medium	medium	NOUN
iajs-3338	72	14	for	for	ADP
iajs-3338	72	15	detecting	detect	VERB
iajs-3338	72	16	oral	oral	ADJ
iajs-3338	72	17	pro	pro	ADJ
iajs-3338	72	18	-	-	ADJ
iajs-3338	72	19	inflammatory	inflammatory	ADJ
iajs-3338	72	20	markers	marker	NOUN
iajs-3338	72	21	.	.	PUNCT
iajs-3338	73	1	the	the	DET
iajs-3338	73	2	concentration	concentration	NOUN
iajs-3338	73	3	of	of	ADP
iajs-3338	73	4	the	the	DET
iajs-3338	73	5	inflammatory	inflammatory	ADJ
iajs-3338	73	6	interleukin	interleukin	NOUN
iajs-3338	73	7	2	2	NUM
iajs-3338	73	8	(	(	PUNCT
iajs-3338	73	9	il-2	il-2	NUM
iajs-3338	73	10	)	)	PUNCT
iajs-3338	73	11	and	and	CCONJ
iajs-3338	73	12	interleukin	interleukin	NOUN
iajs-3338	73	13	12	12	NUM
iajs-3338	73	14	(	(	PUNCT
iajs-3338	73	15	il-12	il-12	NOUN
iajs-3338	73	16	)	)	PUNCT
iajs-3338	73	17	in	in	ADP
iajs-3338	73	18	the	the	DET
iajs-3338	73	19	saliva	saliva	NOUN
iajs-3338	73	20	may	may	AUX
iajs-3338	73	21	also	also	ADV
iajs-3338	73	22	have	have	VERB
iajs-3338	73	23	a	a	DET
iajs-3338	73	24	substantial	substantial	ADJ
iajs-3338	73	25	effect	effect	NOUN
iajs-3338	73	26	on	on	ADP
iajs-3338	73	27	the	the	DET
iajs-3338	73	28	pathogenesis	pathogenesis	NOUN
iajs-3338	73	29	of	of	ADP
iajs-3338	73	30	this	this	DET
iajs-3338	73	31	disease	disease	NOUN
iajs-3338	73	32	.	.	PUNCT
iajs-3338	74	1	acknowledgment	acknowledgment	NOUN
iajs-3338	74	2	many	many	ADJ
iajs-3338	74	3	thanks	thank	NOUN
iajs-3338	74	4	to	to	ADP
iajs-3338	74	5	editor	editor	NOUN
iajs-3338	74	6	-	-	PUNCT
iajs-3338	74	7	in	in	ADP
iajs-3338	74	8	-	-	PUNCT
iajs-3338	74	9	chief	chief	NOUN
iajs-3338	74	10	and	and	CCONJ
iajs-3338	74	11	members	member	NOUN
iajs-3338	74	12	of	of	ADP
iajs-3338	74	13	the	the	DET
iajs-3338	74	14	editorial	editorial	ADJ
iajs-3338	74	15	committee	committee	NOUN
iajs-3338	74	16	in	in	ADP
iajs-3338	74	17	ibn	ibn	PROPN
iajs-3338	74	18	al	al	PROPN
iajs-3338	74	19	-	-	PUNCT
iajs-3338	74	20	haitham	haitham	PROPN
iajs-3338	74	21	journal	journal	PROPN
iajs-3338	74	22	for	for	ADP
iajs-3338	74	23	pure	pure	ADJ
iajs-3338	74	24	and	and	CCONJ
iajs-3338	74	25	applied	applied	ADJ
iajs-3338	74	26	sciences	science	NOUN
iajs-3338	74	27	.	.	PUNCT
iajs-3338	75	1	conflict	conflict	NOUN
iajs-3338	75	2	of	of	ADP
iajs-3338	75	3	interest	interest	NOUN
iajs-3338	75	4	there	there	PRON
iajs-3338	75	5	is	be	VERB
iajs-3338	75	6	no	no	DET
iajs-3338	75	7	conflict	conflict	NOUN
iajs-3338	75	8	of	of	ADP
iajs-3338	75	9	interest	interest	NOUN
iajs-3338	75	10	.	.	PUNCT
iajs-3338	76	1	funding	funding	NOUN
iajs-3338	76	2	there	there	PRON
iajs-3338	76	3	is	be	VERB
iajs-3338	76	4	no	no	DET
iajs-3338	76	5	funding	funding	NOUN
iajs-3338	76	6	for	for	ADP
iajs-3338	76	7	the	the	DET
iajs-3338	76	8	article	article	NOUN
iajs-3338	76	9	.	.	PUNCT
iajs-3338	77	1	patients	patient	NOUN
iajs-3338	77	2	control	control	VERB
iajs-3338	77	3	il-12	il-12	PRON
iajs-3338	77	4	331.32	331.32	NUM
iajs-3338	77	5	130.31	130.31	NUM
iajs-3338	77	6	0	0	NUM
iajs-3338	77	7	50	50	NUM
iajs-3338	77	8	100	100	NUM
iajs-3338	77	9	150	150	NUM
iajs-3338	77	10	200	200	NUM
iajs-3338	77	11	250	250	NUM
iajs-3338	77	12	300	300	NUM
iajs-3338	77	13	350	350	NUM
iajs-3338	77	14	m	m	NOUN
iajs-3338	77	15	e	e	NOUN
iajs-3338	77	16	a	a	DET
iajs-3338	77	17	n	n	NOUN
iajs-3338	77	18	v	v	NOUN
iajs-3338	77	19	a	a	DET
iajs-3338	77	20	lu	lu	NOUN
iajs-3338	77	21	e	e	NOUN
iajs-3338	77	22	il-12	il-12	ADP
iajs-3338	77	23	pg\ml	pg\ml	PROPN
iajs-3338	77	24	ihjpas	ihjpa	NOUN
iajs-3338	77	25	.	.	PUNCT
iajs-3338	78	1	2024	2024	NUM
iajs-3338	78	2	,	,	PUNCT
iajs-3338	78	3	37(4	37(4	NOUN
iajs-3338	78	4	)	)	PUNCT
iajs-3338	78	5	23	23	NUM
iajs-3338	78	6	references	reference	NOUN
iajs-3338	78	7	1	1	NUM
iajs-3338	78	8	.	.	PUNCT
iajs-3338	79	1	al	al	PROPN
iajs-3338	79	2	-	-	PUNCT
iajs-3338	79	3	ghurabei	ghurabei	PROPN
iajs-3338	79	4	,	,	PUNCT
iajs-3338	79	5	b.h	b.h	PROPN
iajs-3338	79	6	.	.	NOUN
iajs-3338	79	7	role	role	NOUN
iajs-3338	79	8	of	of	ADP
iajs-3338	79	9	salivary	salivary	ADJ
iajs-3338	79	10	tumor	tumor	NOUN
iajs-3338	79	11	necrosis	necrosis	NOUN
iajs-3338	79	12	factor	factor	NOUN
iajs-3338	79	13	-	-	PUNCT
iajs-3338	79	14	alpha	alpha	NOUN
iajs-3338	79	15	and	and	CCONJ
iajs-3338	79	16	immunoglobulin	immunoglobulin	NOUN
iajs-3338	79	17	-	-	PUNCT
iajs-3338	79	18	a	a	NOUN
iajs-3338	79	19	in	in	ADP
iajs-3338	79	20	recurrent	recurrent	ADJ
iajs-3338	79	21	aphthous	aphthous	ADJ
iajs-3338	79	22	stomatitis	stomatitis	NOUN
iajs-3338	79	23	.	.	PUNCT
iajs-3338	80	1	journal	journal	NOUN
iajs-3338	80	2	of	of	ADP
iajs-3338	80	3	the	the	DET
iajs-3338	80	4	faculty	faculty	NOUN
iajs-3338	80	5	of	of	ADP
iajs-3338	80	6	medicine	medicine	NOUN
iajs-3338	80	7	baghdad	baghdad	PROPN
iajs-3338	80	8	2011	2011	NUM
iajs-3338	80	9	,	,	PUNCT
iajs-3338	80	10	53(2	53(2	NUM
iajs-3338	80	11	)	)	PUNCT
iajs-3338	80	12	,	,	PUNCT
iajs-3338	80	13	207	207	NUM
iajs-3338	80	14	-	-	SYM
iajs-3338	80	15	210	210	NUM
iajs-3338	80	16	.	.	PUNCT
iajs-3338	81	1	https://doi.org/10.32007/jfacmedbagdad.532876	https://doi.org/10.32007/jfacmedbagdad.532876	NOUN
iajs-3338	81	2	.	.	PROPN
iajs-3338	81	3	2	2	NUM
iajs-3338	81	4	.	.	X
iajs-3338	81	5	akintoye	akintoye	PROPN
iajs-3338	81	6	,	,	PUNCT
iajs-3338	81	7	s.o	s.o	PROPN
iajs-3338	81	8	.	.	PROPN
iajs-3338	81	9	;	;	PUNCT
iajs-3338	81	10	greenberg	greenberg	PROPN
iajs-3338	81	11	,	,	PUNCT
iajs-3338	81	12	m.	m.	NOUN
iajs-3338	81	13	s.	s.	PROPN
iajs-3338	81	14	(	(	PUNCT
iajs-3338	81	15	2014	2014	NUM
iajs-3338	81	16	)	)	PUNCT
iajs-3338	81	17	.	.	PUNCT
iajs-3338	82	1	recurrent	recurrent	ADJ
iajs-3338	82	2	aphthous	aphthous	ADJ
iajs-3338	82	3	stomatitis	stomatitis	NOUN
iajs-3338	82	4	.	.	PUNCT
iajs-3338	83	1	dental	dental	ADJ
iajs-3338	83	2	clinics	clinic	NOUN
iajs-3338	83	3	of	of	ADP
iajs-3338	83	4	north	north	PROPN
iajs-3338	83	5	america	america	PROPN
iajs-3338	83	6	2014	2014	NUM
iajs-3338	83	7	,	,	PUNCT
iajs-3338	83	8	58(2	58(2	NUM
iajs-3338	83	9	)	)	PUNCT
iajs-3338	83	10	,	,	PUNCT
iajs-3338	83	11	281–297	281–297	NUM
iajs-3338	83	12	.	.	PUNCT
iajs-3338	83	13	https://doi.org/10.1016/j.cden.2013.12.002	https://doi.org/10.1016/j.cden.2013.12.002	NOUN
iajs-3338	83	14	.	.	PUNCT
iajs-3338	84	1	3	3	X
iajs-3338	84	2	.	.	X
iajs-3338	84	3	al	al	PROPN
iajs-3338	84	4	-	-	PUNCT
iajs-3338	84	5	ani	ani	PROPN
iajs-3338	84	6	,	,	PUNCT
iajs-3338	84	7	r.h	r.h	PROPN
iajs-3338	84	8	.	.	PROPN
iajs-3338	84	9	;	;	PUNCT
iajs-3338	84	10	shaker	shaker	PROPN
iajs-3338	84	11	,	,	PUNCT
iajs-3338	84	12	a.w	a.w	PROPN
iajs-3338	84	13	.	.	PROPN
iajs-3338	84	14	;	;	PUNCT
iajs-3338	84	15	ibrahim	ibrahim	PROPN
iajs-3338	84	16	,	,	PUNCT
iajs-3338	84	17	l.m	l.m	PROPN
iajs-3338	84	18	.	.	PROPN
iajs-3338	84	19	correlation	correlation	NOUN
iajs-3338	84	20	between	between	ADP
iajs-3338	84	21	salivary	salivary	ADJ
iajs-3338	84	22	cotinine	cotinine	NOUN
iajs-3338	84	23	levels	level	NOUN
iajs-3338	84	24	and	and	CCONJ
iajs-3338	84	25	cigarette	cigarette	NOUN
iajs-3338	84	26	smoking	smoking	NOUN
iajs-3338	84	27	with	with	ADP
iajs-3338	84	28	recurrent	recurrent	ADJ
iajs-3338	84	29	aphthous	aphthous	ADJ
iajs-3338	84	30	stomatitis	stomatitis	NOUN
iajs-3338	84	31	.	.	PUNCT
iajs-3338	85	1	indian	indian	PROPN
iajs-3338	85	2	journal	journal	PROPN
iajs-3338	85	3	of	of	ADP
iajs-3338	85	4	forensic	forensic	ADJ
iajs-3338	85	5	medicine	medicine	NOUN
iajs-3338	85	6	&	&	CCONJ
iajs-3338	85	7	toxicology	toxicology	NOUN
iajs-3338	85	8	2021	2021	NUM
iajs-3338	85	9	,	,	PUNCT
iajs-3338	85	10	15(2	15(2	NUM
iajs-3338	85	11	)	)	PUNCT
iajs-3338	85	12	,	,	PUNCT
iajs-3338	85	13	3258	3258	NUM
iajs-3338	85	14	-	-	SYM
iajs-3338	85	15	3263	3263	NUM
iajs-3338	85	16	.	.	PUNCT
iajs-3338	86	1	4	4	NUM
iajs-3338	86	2	.	.	X
iajs-3338	86	3	plewa	plewa	PROPN
iajs-3338	86	4	,	,	PUNCT
iajs-3338	86	5	m.c	m.c	PROPN
iajs-3338	86	6	.	.	PROPN
iajs-3338	86	7	;	;	PUNCT
iajs-3338	86	8	chatterjee	chatterjee	PROPN
iajs-3338	86	9	,	,	PUNCT
iajs-3338	86	10	k.	k.	PROPN
iajs-3338	86	11	recurrent	recurrent	ADJ
iajs-3338	86	12	aphthous	aphthous	ADJ
iajs-3338	86	13	stomatitis	stomatitis	NOUN
iajs-3338	86	14	.	.	PUNCT
iajs-3338	87	1	in	in	ADP
iajs-3338	87	2	:	:	PUNCT
iajs-3338	87	3	statpearls	statpearl	NOUN
iajs-3338	88	1	[	[	X
iajs-3338	88	2	internet	internet	NOUN
iajs-3338	88	3	]	]	PUNCT
iajs-3338	88	4	.	.	PUNCT
iajs-3338	89	1	treasure	treasure	NOUN
iajs-3338	89	2	island	island	NOUN
iajs-3338	89	3	(	(	PUNCT
iajs-3338	89	4	fl	fl	PROPN
iajs-3338	89	5	):	):	PUNCT
iajs-3338	89	6	statpearls	statpearl	NOUN
iajs-3338	89	7	publishing	publishing	NOUN
iajs-3338	89	8	;	;	PUNCT
iajs-3338	89	9	2024	2024	NUM
iajs-3338	89	10	.	.	PUNCT
iajs-3338	90	1	available	available	ADJ
iajs-3338	90	2	from	from	ADP
iajs-3338	90	3	:	:	PUNCT
iajs-3338	90	4	https://www.ncbi.nlm.nih.gov/books/nbk431059/.	https://www.ncbi.nlm.nih.gov/books/nbk431059/.	PROPN
iajs-3338	90	5	5	5	NUM
iajs-3338	90	6	.	.	X
iajs-3338	90	7	ali	ali	PROPN
iajs-3338	90	8	,	,	PUNCT
iajs-3338	90	9	n.s.m	n.s.m	PROPN
iajs-3338	90	10	.	.	PROPN
iajs-3338	90	11	serum	serum	PROPN
iajs-3338	90	12	ferritin	ferritin	ADJ
iajs-3338	90	13	level	level	NOUN
iajs-3338	90	14	and	and	CCONJ
iajs-3338	90	15	b12	b12	NOUN
iajs-3338	90	16	in	in	ADP
iajs-3338	90	17	a	a	DET
iajs-3338	90	18	sample	sample	NOUN
iajs-3338	90	19	of	of	ADP
iajs-3338	90	20	iraqi	iraqi	ADJ
iajs-3338	90	21	re	re	ADJ
iajs-3338	90	22	-	-	ADJ
iajs-3338	90	23	current	current	ADJ
iajs-3338	90	24	aphthous	aphthous	ADJ
iajs-3338	90	25	stomatitis	stomatitis	NOUN
iajs-3338	90	26	patients	patient	NOUN
iajs-3338	90	27	.	.	PUNCT
iajs-3338	91	1	journal	journal	PROPN
iajs-3338	91	2	of	of	ADP
iajs-3338	91	3	baghdad	baghdad	PROPN
iajs-3338	91	4	college	college	PROPN
iajs-3338	91	5	of	of	ADP
iajs-3338	91	6	dentistry	dentistry	NOUN
iajs-3338	91	7	2022	2022	NUM
iajs-3338	91	8	,	,	PUNCT
iajs-3338	91	9	34(3	34(3	NUM
iajs-3338	91	10	)	)	PUNCT
iajs-3338	91	11	,	,	PUNCT
iajs-3338	91	12	1	1	NUM
iajs-3338	91	13	-	-	SYM
iajs-3338	91	14	6	6	NUM
iajs-3338	91	15	.	.	NOUN
iajs-3338	91	16	https://doi.org/10.26477/jbcd.v34i3.3211	https://doi.org/10.26477/jbcd.v34i3.3211	NOUN
iajs-3338	91	17	.	.	PUNCT
iajs-3338	92	1	6	6	NUM
iajs-3338	92	2	.	.	X
iajs-3338	92	3	al	al	PROPN
iajs-3338	92	4	-	-	PUNCT
iajs-3338	92	5	essa	essa	PROPN
iajs-3338	92	6	,	,	PUNCT
iajs-3338	92	7	h.s	h.s	PROPN
iajs-3338	92	8	.	.	PROPN
iajs-3338	92	9	;	;	PUNCT
iajs-3338	92	10	zaidan	zaidan	PROPN
iajs-3338	92	11	,	,	PUNCT
iajs-3338	92	12	t.	t.	PROPN
iajs-3338	92	13	f.	f.	PROPN
iajs-3338	92	14	assessment	assessment	NOUN
iajs-3338	92	15	of	of	ADP
iajs-3338	92	16	serum	serum	NOUN
iajs-3338	92	17	and	and	CCONJ
iajs-3338	92	18	salivary	salivary	VERB
iajs-3338	92	19	oxidant	oxidant	NOUN
iajs-3338	92	20	and	and	CCONJ
iajs-3338	92	21	total	total	ADJ
iajs-3338	92	22	antioxidant	antioxidant	ADJ
iajs-3338	92	23	status	status	NOUN
iajs-3338	92	24	of	of	ADP
iajs-3338	92	25	patients	patient	NOUN
iajs-3338	92	26	with	with	ADP
iajs-3338	92	27	recurrent	recurrent	ADJ
iajs-3338	92	28	aphthous	aphthous	ADJ
iajs-3338	92	29	stomatitis	stomatitis	NOUN
iajs-3338	92	30	in	in	ADP
iajs-3338	92	31	a	a	DET
iajs-3338	92	32	sample	sample	NOUN
iajs-3338	92	33	of	of	ADP
iajs-3338	92	34	basrah	basrah	PROPN
iajs-3338	92	35	city	city	PROPN
iajs-3338	92	36	.	.	PUNCT
iajs-3338	93	1	journal	journal	PROPN
iajs-3338	93	2	of	of	ADP
iajs-3338	93	3	baghdad	baghdad	PROPN
iajs-3338	93	4	college	college	PROPN
iajs-3338	93	5	of	of	ADP
iajs-3338	93	6	dentistry	dentistry	NOUN
iajs-3338	93	7	2013	2013	NUM
iajs-3338	93	8	,	,	PUNCT
iajs-3338	93	9	25(special	25(special	NUM
iajs-3338	93	10	is	be	AUX
iajs-3338	93	11	)	)	PUNCT
iajs-3338	93	12	,	,	PUNCT
iajs-3338	93	13	83	83	NUM
iajs-3338	93	14	-	-	SYM
iajs-3338	93	15	88	88	NUM
iajs-3338	93	16	.	.	PUNCT
iajs-3338	94	1	https://jbcd.uobaghdad.edu.iq/index.php/jbcd/article/view/204	https://jbcd.uobaghdad.edu.iq/index.php/jbcd/article/view/204	PROPN
iajs-3338	94	2	.	.	PUNCT
iajs-3338	95	1	7	7	X
iajs-3338	95	2	.	.	X
iajs-3338	95	3	altaei	altaei	PROPN
iajs-3338	95	4	,	,	PUNCT
iajs-3338	95	5	t.	t.	PROPN
iajs-3338	95	6	;	;	PUNCT
iajs-3338	95	7	ahmed	ahmed	PROPN
iajs-3338	95	8	,	,	PUNCT
iajs-3338	95	9	s.a	s.a	PROPN
iajs-3338	95	10	.	.	PROPN
iajs-3338	95	11	;	;	PUNCT
iajs-3338	96	1	haider	haider	PROPN
iajs-3338	96	2	,	,	PUNCT
iajs-3338	96	3	a.a	a.a	PROPN
iajs-3338	96	4	.	.	PROPN
iajs-3338	96	5	efficacy	efficacy	NOUN
iajs-3338	96	6	of	of	ADP
iajs-3338	96	7	topical	topical	ADJ
iajs-3338	96	8	flax	flax	NOUN
iajs-3338	96	9	paint	paint	NOUN
iajs-3338	96	10	for	for	ADP
iajs-3338	96	11	the	the	DET
iajs-3338	96	12	treatment	treatment	NOUN
iajs-3338	96	13	of	of	ADP
iajs-3338	96	14	recurrent	recurrent	ADJ
iajs-3338	96	15	aphthous	aphthous	ADJ
iajs-3338	96	16	stomatitis	stomatitis	NOUN
iajs-3338	96	17	.	.	PUNCT
iajs-3338	97	1	journal	journal	PROPN
iajs-3338	97	2	of	of	ADP
iajs-3338	97	3	baghdad	baghdad	PROPN
iajs-3338	97	4	college	college	PROPN
iajs-3338	97	5	of	of	ADP
iajs-3338	97	6	dentistry	dentistry	NOUN
iajs-3338	97	7	2011	2011	NUM
iajs-3338	97	8	,	,	PUNCT
iajs-3338	97	9	23	23	NUM
iajs-3338	97	10	,	,	PUNCT
iajs-3338	97	11	100	100	NUM
iajs-3338	97	12	-	-	SYM
iajs-3338	97	13	107	107	NUM
iajs-3338	97	14	.	.	PUNCT
iajs-3338	98	1	8	8	NUM
iajs-3338	98	2	.	.	X
iajs-3338	98	3	saeed	saeed	PROPN
iajs-3338	98	4	,	,	PUNCT
iajs-3338	98	5	s.a	s.a	PROPN
iajs-3338	98	6	.	.	PROPN
iajs-3338	98	7	;	;	PUNCT
iajs-3338	98	8	zaidan	zaidan	PROPN
iajs-3338	98	9	,	,	PUNCT
iajs-3338	98	10	t.	t.	PROPN
iajs-3338	98	11	f.	f.	PROPN
iajs-3338	98	12	clinical	clinical	PROPN
iajs-3338	98	13	evaluation	evaluation	NOUN
iajs-3338	98	14	of	of	ADP
iajs-3338	98	15	recurrent	recurrent	ADJ
iajs-3338	98	16	aphthous	aphthous	ADJ
iajs-3338	98	17	stomatitis	stomatitis	NOUN
iajs-3338	98	18	and	and	CCONJ
iajs-3338	98	19	its	its	PRON
iajs-3338	98	20	correlation	correlation	NOUN
iajs-3338	98	21	with	with	ADP
iajs-3338	98	22	helicobacter	helicobacter	NOUN
iajs-3338	98	23	pylori	pylori	NOUN
iajs-3338	98	24	.	.	PUNCT
iajs-3338	99	1	indian	indian	ADJ
iajs-3338	99	2	journal	journal	PROPN
iajs-3338	99	3	of	of	ADP
iajs-3338	99	4	forensic	forensic	ADJ
iajs-3338	99	5	medicine	medicine	NOUN
iajs-3338	99	6	&	&	CCONJ
iajs-3338	99	7	toxicology	toxicology	NOUN
iajs-3338	99	8	2020	2020	NUM
iajs-3338	99	9	,	,	PUNCT
iajs-3338	99	10	14(4	14(4	NUM
iajs-3338	99	11	)	)	PUNCT
iajs-3338	99	12	,	,	PUNCT
iajs-3338	99	13	21542159	21542159	NUM
iajs-3338	99	14	.	.	PUNCT
iajs-3338	100	1	https://doi.org/10.37506/ijfmt.v14i4.11870	https://doi.org/10.37506/ijfmt.v14i4.11870	X
iajs-3338	100	2	.	.	PUNCT
iajs-3338	101	1	9	9	X
iajs-3338	101	2	.	.	X
iajs-3338	101	3	shen	shen	PROPN
iajs-3338	101	4	,	,	PUNCT
iajs-3338	101	5	c.	c.	PROPN
iajs-3338	101	6	;	;	PUNCT
iajs-3338	101	7	ye	ye	PROPN
iajs-3338	101	8	,	,	PUNCT
iajs-3338	101	9	w.	w.	PROPN
iajs-3338	101	10	;	;	PUNCT
iajs-3338	101	11	gong	gong	PROPN
iajs-3338	101	12	,	,	PUNCT
iajs-3338	101	13	l.	l.	PROPN
iajs-3338	101	14	;	;	PUNCT
iajs-3338	101	15	lv	lv	PROPN
iajs-3338	101	16	,	,	PUNCT
iajs-3338	101	17	k.	k.	PROPN
iajs-3338	101	18	;	;	PUNCT
iajs-3338	101	19	gao	gao	PROPN
iajs-3338	101	20	,	,	PUNCT
iajs-3338	101	21	b.	b.	PROPN
iajs-3338	101	22	;	;	PUNCT
iajs-3338	101	23	yao	yao	PROPN
iajs-3338	101	24	,	,	PUNCT
iajs-3338	101	25	h.	h.	PROPN
iajs-3338	101	26	serum	serum	PROPN
iajs-3338	101	27	interleukin-6	interleukin-6	PROPN
iajs-3338	101	28	,	,	PUNCT
iajs-3338	101	29	interleukin-17a	interleukin-17a	PROPN
iajs-3338	101	30	,	,	PUNCT
iajs-3338	101	31	and	and	CCONJ
iajs-3338	101	32	tumor	tumor	NOUN
iajs-3338	101	33	necrosis	necrosis	NOUN
iajs-3338	101	34	factor	factor	NOUN
iajs-3338	101	35	-	-	PUNCT
iajs-3338	101	36	alpha	alpha	NOUN
iajs-3338	101	37	in	in	ADP
iajs-3338	101	38	patients	patient	NOUN
iajs-3338	101	39	with	with	ADP
iajs-3338	101	40	recurrent	recurrent	ADJ
iajs-3338	101	41	aphthous	aphthous	ADJ
iajs-3338	101	42	stomatitis	stomatitis	NOUN
iajs-3338	101	43	.	.	PUNCT
iajs-3338	102	1	journal	journal	PROPN
iajs-3338	102	2	of	of	ADP
iajs-3338	102	3	oral	oral	ADJ
iajs-3338	102	4	pathology	pathology	NOUN
iajs-3338	102	5	&	&	CCONJ
iajs-3338	102	6	medicine	medicine	PROPN
iajs-3338	102	7	2021	2021	NUM
iajs-3338	102	8	,	,	PUNCT
iajs-3338	102	9	50(4	50(4	NUM
iajs-3338	102	10	)	)	PUNCT
iajs-3338	102	11	,	,	PUNCT
iajs-3338	102	12	418	418	NUM
iajs-3338	102	13	-	-	SYM
iajs-3338	102	14	423	423	NUM
iajs-3338	102	15	.	.	PUNCT
iajs-3338	103	1	https://doi.org/10.1111/jop.13158	https://doi.org/10.1111/jop.13158	NOUN
iajs-3338	103	2	.	.	PUNCT
iajs-3338	104	1	10	10	NUM
iajs-3338	104	2	.	.	X
iajs-3338	105	1	elamrousy	elamrousy	PROPN
iajs-3338	105	2	,	,	PUNCT
iajs-3338	105	3	w.a	w.a	PROPN
iajs-3338	105	4	.	.	PROPN
iajs-3338	105	5	;	;	PUNCT
iajs-3338	105	6	mortada	mortada	PROPN
iajs-3338	105	7	,	,	PUNCT
iajs-3338	105	8	a.	a.	NOUN
iajs-3338	105	9	;	;	PUNCT
iajs-3338	105	10	shoukheba	shoukheba	PROPN
iajs-3338	105	11	,	,	PUNCT
iajs-3338	105	12	m.	m.	NOUN
iajs-3338	105	13	evaluation	evaluation	NOUN
iajs-3338	105	14	of	of	ADP
iajs-3338	105	15	novel	novel	ADJ
iajs-3338	105	16	topical	topical	ADJ
iajs-3338	105	17	camel	camel	NOUN
iajs-3338	105	18	whey	whey	PROPN
iajs-3338	105	19	protein	protein	NOUN
iajs-3338	105	20	gel	gel	NOUN
iajs-3338	105	21	for	for	ADP
iajs-3338	105	22	the	the	DET
iajs-3338	105	23	treatment	treatment	NOUN
iajs-3338	105	24	of	of	ADP
iajs-3338	105	25	recurrent	recurrent	ADJ
iajs-3338	105	26	aphthous	aphthous	ADJ
iajs-3338	105	27	stomatitis	stomatitis	NOUN
iajs-3338	105	28	:	:	PUNCT
iajs-3338	105	29	randomized	randomize	VERB
iajs-3338	105	30	clinical	clinical	ADJ
iajs-3338	105	31	study	study	NOUN
iajs-3338	105	32	.	.	PUNCT
iajs-3338	106	1	journal	journal	PROPN
iajs-3338	106	2	of	of	ADP
iajs-3338	106	3	international	international	ADJ
iajs-3338	106	4	society	society	NOUN
iajs-3338	106	5	of	of	ADP
iajs-3338	106	6	preventive	preventive	ADJ
iajs-3338	106	7	&	&	CCONJ
iajs-3338	106	8	community	community	NOUN
iajs-3338	106	9	dentistry	dentistry	NOUN
iajs-3338	106	10	2021	2021	NUM
iajs-3338	106	11	,	,	PUNCT
iajs-3338	106	12	11(5	11(5	NUM
iajs-3338	106	13	)	)	PUNCT
iajs-3338	106	14	,	,	PUNCT
iajs-3338	106	15	574–581	574–581	NUM
iajs-3338	106	16	.	.	PUNCT
iajs-3338	107	1	https://doi.org/10.4103/jispcd.jispcd_172_21	https://doi.org/10.4103/jispcd.jispcd_172_21	X
iajs-3338	107	2	.	.	PROPN
iajs-3338	107	3	11	11	NUM
iajs-3338	107	4	.	.	X
iajs-3338	108	1	lau	lau	PROPN
iajs-3338	108	2	,	,	PUNCT
iajs-3338	108	3	c.b	c.b	PROPN
iajs-3338	108	4	.	.	PROPN
iajs-3338	108	5	;	;	PUNCT
iajs-3338	108	6	smith	smith	PROPN
iajs-3338	108	7	,	,	PUNCT
iajs-3338	108	8	g.p	g.p	PROPN
iajs-3338	108	9	.	.	PROPN
iajs-3338	108	10	recurrent	recurrent	ADJ
iajs-3338	108	11	aphthous	aphthous	ADJ
iajs-3338	108	12	stomatitis	stomatitis	NOUN
iajs-3338	108	13	:	:	PUNCT
iajs-3338	108	14	a	a	DET
iajs-3338	108	15	comprehensive	comprehensive	ADJ
iajs-3338	108	16	review	review	NOUN
iajs-3338	108	17	and	and	CCONJ
iajs-3338	108	18	recommendations	recommendation	NOUN
iajs-3338	108	19	on	on	ADP
iajs-3338	108	20	therapeutic	therapeutic	ADJ
iajs-3338	108	21	options	option	NOUN
iajs-3338	108	22	.	.	PUNCT
iajs-3338	109	1	dermatologic	dermatologic	ADJ
iajs-3338	109	2	therapy	therapy	NOUN
iajs-3338	109	3	2022	2022	NUM
iajs-3338	109	4	,	,	PUNCT
iajs-3338	109	5	35(6	35(6	NUM
iajs-3338	109	6	)	)	PUNCT
iajs-3338	109	7	,	,	PUNCT
iajs-3338	109	8	e15500.https://doi.org/10.1111/dth.15500	e15500.https://doi.org/10.1111/dth.15500	NOUN
iajs-3338	109	9	.	.	PUNCT
iajs-3338	109	10	12	12	NUM
iajs-3338	109	11	.	.	PUNCT
iajs-3338	110	1	belenguer	belenguer	NOUN
iajs-3338	110	2	-	-	PUNCT
iajs-3338	110	3	guallar	guallar	ADJ
iajs-3338	110	4	,	,	PUNCT
iajs-3338	110	5	i.	i.	NOUN
iajs-3338	110	6	;	;	PUNCT
iajs-3338	110	7	jiménez	jiménez	PROPN
iajs-3338	110	8	-	-	PUNCT
iajs-3338	110	9	soriano	soriano	PROPN
iajs-3338	110	10	,	,	PUNCT
iajs-3338	110	11	y.	y.	PROPN
iajs-3338	110	12	;	;	PUNCT
iajs-3338	110	13	claramunt	claramunt	PROPN
iajs-3338	110	14	-	-	PUNCT
iajs-3338	110	15	lozano	lozano	PROPN
iajs-3338	110	16	,	,	PUNCT
iajs-3338	110	17	a.	a.	NOUN
iajs-3338	110	18	(	(	PUNCT
iajs-3338	110	19	2014	2014	NUM
iajs-3338	110	20	)	)	PUNCT
iajs-3338	110	21	.	.	PUNCT
iajs-3338	111	1	treatment	treatment	NOUN
iajs-3338	111	2	of	of	ADP
iajs-3338	111	3	recurrent	recurrent	ADJ
iajs-3338	111	4	aphthous	aphthous	ADJ
iajs-3338	111	5	stomatitis	stomatitis	NOUN
iajs-3338	111	6	.	.	PUNCT
iajs-3338	112	1	a	a	DET
iajs-3338	112	2	literature	literature	PROPN
iajs-3338	112	3	review	review	NOUN
iajs-3338	112	4	.	.	PUNCT
iajs-3338	113	1	journal	journal	PROPN
iajs-3338	113	2	of	of	ADP
iajs-3338	113	3	clinical	clinical	ADJ
iajs-3338	113	4	and	and	CCONJ
iajs-3338	113	5	experimental	experimental	ADJ
iajs-3338	113	6	dentistry	dentistry	NOUN
iajs-3338	113	7	2014	2014	NUM
iajs-3338	113	8	,	,	PUNCT
iajs-3338	113	9	6(2	6(2	NUM
iajs-3338	113	10	)	)	PUNCT
iajs-3338	113	11	,	,	PUNCT
iajs-3338	113	12	e168	e168	PROPN
iajs-3338	113	13	–	–	PUNCT
iajs-3338	113	14	e174	e174	NUM
iajs-3338	113	15	.	.	PUNCT
iajs-3338	114	1	https://doi.org/10.4317/jced.51401	https://doi.org/10.4317/jced.51401	PROPN
iajs-3338	114	2	.	.	PROPN
iajs-3338	115	1	13	13	NUM
iajs-3338	115	2	.	.	PUNCT
iajs-3338	116	1	buno	buno	PROPN
iajs-3338	116	2	,	,	PUNCT
iajs-3338	116	3	i.j	i.j	PROPN
iajs-3338	116	4	.	.	PROPN
iajs-3338	116	5	;	;	PUNCT
iajs-3338	116	6	huff	huff	PROPN
iajs-3338	116	7	,	,	PUNCT
iajs-3338	116	8	j.c	j.c	PROPN
iajs-3338	116	9	.	.	PROPN
iajs-3338	116	10	;	;	PUNCT
iajs-3338	116	11	weston	weston	PROPN
iajs-3338	116	12	,	,	PUNCT
iajs-3338	116	13	w.l	w.l	PROPN
iajs-3338	116	14	.	.	PROPN
iajs-3338	116	15	;	;	PUNCT
iajs-3338	116	16	cook	cook	VERB
iajs-3338	116	17	,	,	PUNCT
iajs-3338	116	18	d.t	d.t	PROPN
iajs-3338	116	19	.	.	PROPN
iajs-3338	116	20	;	;	PUNCT
iajs-3338	116	21	brice	brice	PROPN
iajs-3338	116	22	,	,	PUNCT
iajs-3338	116	23	s.	s.	PROPN
iajs-3338	116	24	l.	l.	PROPN
iajs-3338	116	25	elevated	elevated	PROPN
iajs-3338	116	26	levels	level	NOUN
iajs-3338	116	27	of	of	ADP
iajs-3338	116	28	interferon	interferon	ADJ
iajs-3338	116	29	gamma	gamma	NOUN
iajs-3338	116	30	,	,	PUNCT
iajs-3338	116	31	tumor	tumor	NOUN
iajs-3338	116	32	necrosis	necrosis	NOUN
iajs-3338	116	33	factor	factor	NOUN
iajs-3338	116	34	α	α	NOUN
iajs-3338	116	35	,	,	PUNCT
iajs-3338	116	36	interleukins	interleukin	VERB
iajs-3338	116	37	2	2	NUM
iajs-3338	116	38	,	,	PUNCT
iajs-3338	116	39	4	4	NUM
iajs-3338	116	40	,	,	PUNCT
iajs-3338	116	41	and	and	CCONJ
iajs-3338	116	42	5	5	NUM
iajs-3338	116	43	,	,	PUNCT
iajs-3338	116	44	but	but	CCONJ
iajs-3338	116	45	not	not	PART
iajs-3338	116	46	interleukin	interleukin	NOUN
iajs-3338	116	47	10	10	NUM
iajs-3338	116	48	,	,	PUNCT
iajs-3338	116	49	are	be	AUX
iajs-3338	116	50	present	present	ADJ
iajs-3338	116	51	in	in	ADP
iajs-3338	116	52	recurrent	recurrent	ADJ
iajs-3338	116	53	aphthous	aphthous	ADJ
iajs-3338	116	54	stomatitis	stomatitis	NOUN
iajs-3338	116	55	.	.	PUNCT
iajs-3338	117	1	archives	archive	NOUN
iajs-3338	117	2	of	of	ADP
iajs-3338	117	3	dermatology	dermatology	NOUN
iajs-3338	117	4	1998	1998	NUM
iajs-3338	117	5	,	,	PUNCT
iajs-3338	117	6	134(7	134(7	NUM
iajs-3338	117	7	)	)	PUNCT
iajs-3338	117	8	,	,	PUNCT
iajs-3338	117	9	827	827	NUM
iajs-3338	117	10	-	-	SYM
iajs-3338	117	11	831	831	NUM
iajs-3338	117	12	.	.	PUNCT
iajs-3338	118	1	https://doi.org/10.1001/archderm.134.7.827	https://doi.org/10.1001/archderm.134.7.827	X
iajs-3338	118	2	.	.	PUNCT
iajs-3338	119	1	14	14	NUM
iajs-3338	119	2	.	.	X
iajs-3338	119	3	pärssinen	pärssinen	NOUN
iajs-3338	119	4	,	,	PUNCT
iajs-3338	119	5	m.	m.	NOUN
iajs-3338	119	6	;	;	PUNCT
iajs-3338	119	7	jäsberg	jäsberg	PROPN
iajs-3338	119	8	,	,	PUNCT
iajs-3338	119	9	h.	h.	PROPN
iajs-3338	119	10	;	;	PUNCT
iajs-3338	119	11	mikkonen	mikkonen	NOUN
iajs-3338	119	12	,	,	PUNCT
iajs-3338	119	13	j.j.w	j.j.w	PROPN
iajs-3338	119	14	.	.	PROPN
iajs-3338	119	15	;	;	PUNCT
iajs-3338	119	16	kullaa	kullaa	NOUN
iajs-3338	119	17	,	,	PUNCT
iajs-3338	119	18	a.m.	a.m.	PROPN
iajs-3338	119	19	oral	oral	ADJ
iajs-3338	119	20	mucosal	mucosal	NOUN
iajs-3338	119	21	pellicle	pellicle	NOUN
iajs-3338	119	22	as	as	ADP
iajs-3338	119	23	an	an	DET
iajs-3338	119	24	immune	immune	ADJ
iajs-3338	119	25	protection	protection	NOUN
iajs-3338	119	26	against	against	ADP
iajs-3338	119	27	micro	micro	NOUN
iajs-3338	119	28	-	-	NOUN
iajs-3338	119	29	organisms	organism	NOUN
iajs-3338	119	30	in	in	ADP
iajs-3338	119	31	patients	patient	NOUN
iajs-3338	119	32	with	with	ADP
iajs-3338	119	33	recurrent	recurrent	ADJ
iajs-3338	119	34	aphthous	aphthous	ADJ
iajs-3338	119	35	stomatitis	stomatitis	NOUN
iajs-3338	119	36	:	:	PUNCT
iajs-3338	119	37	a	a	DET
iajs-3338	119	38	hypothesis	hypothesis	NOUN
iajs-3338	119	39	.	.	PUNCT
iajs-3338	120	1	medical	medical	ADJ
iajs-3338	120	2	hypotheses	hypothesis	NOUN
iajs-3338	120	3	2021	2021	NUM
iajs-3338	120	4	,	,	PUNCT
iajs-3338	120	5	146	146	NUM
iajs-3338	120	6	,	,	PUNCT
iajs-3338	120	7	110449	110449	NUM
iajs-3338	120	8	.	.	PUNCT
iajs-3338	121	1	https://doi.org/10.1016/j.mehy.2020.110449	https://doi.org/10.1016/j.mehy.2020.110449	PROPN
iajs-3338	121	2	.	.	PUNCT
iajs-3338	122	1	15	15	NUM
iajs-3338	122	2	.	.	PUNCT
iajs-3338	123	1	pelaez	pelaez	NOUN
iajs-3338	123	2	-	-	PUNCT
iajs-3338	123	3	prestel	prestel	NOUN
iajs-3338	123	4	,	,	PUNCT
iajs-3338	123	5	h.f	h.f	PROPN
iajs-3338	123	6	.	.	PROPN
iajs-3338	123	7	;	;	PUNCT
iajs-3338	123	8	sanchez	sanchez	NOUN
iajs-3338	123	9	-	-	PUNCT
iajs-3338	123	10	trincado	trincado	NOUN
iajs-3338	123	11	,	,	PUNCT
iajs-3338	123	12	j.l	j.l	PROPN
iajs-3338	123	13	.	.	PROPN
iajs-3338	123	14	;	;	PUNCT
iajs-3338	123	15	lafuente	lafuente	PROPN
iajs-3338	123	16	,	,	PUNCT
iajs-3338	123	17	e.m	e.m	PROPN
iajs-3338	123	18	.	.	PROPN
iajs-3338	123	19	;	;	PUNCT
iajs-3338	123	20	reche	reche	PROPN
iajs-3338	123	21	,	,	PUNCT
iajs-3338	123	22	p.a	p.a	PROPN
iajs-3338	123	23	.	.	PROPN
iajs-3338	123	24	(	(	PUNCT
iajs-3338	123	25	2021	2021	NUM
iajs-3338	123	26	)	)	PUNCT
iajs-3338	123	27	.	.	PUNCT
iajs-3338	124	1	immune	immune	ADJ
iajs-3338	124	2	tolerance	tolerance	NOUN
iajs-3338	124	3	in	in	ADP
iajs-3338	124	4	the	the	DET
iajs-3338	124	5	oral	oral	ADJ
iajs-3338	124	6	mucosa	mucosa	NOUN
iajs-3338	124	7	.	.	PUNCT
iajs-3338	125	1	international	international	ADJ
iajs-3338	125	2	journal	journal	NOUN
iajs-3338	125	3	of	of	ADP
iajs-3338	125	4	molecular	molecular	ADJ
iajs-3338	125	5	sciences	science	NOUN
iajs-3338	125	6	2021	2021	NUM
iajs-3338	125	7	,	,	PUNCT
iajs-3338	125	8	22(22	22(22	NUM
iajs-3338	125	9	)	)	PUNCT
iajs-3338	125	10	,	,	PUNCT
iajs-3338	125	11	12149	12149	NUM
iajs-3338	125	12	.	.	PUNCT
iajs-3338	126	1	https://doi.org/10.3390/ijms222212149	https://doi.org/10.3390/ijms222212149	PROPN
iajs-3338	126	2	.	.	PUNCT
iajs-3338	127	1	16	16	NUM
iajs-3338	127	2	.	.	PUNCT
iajs-3338	128	1	lin	lin	PROPN
iajs-3338	128	2	,	,	PUNCT
iajs-3338	128	3	d.	d.	PROPN
iajs-3338	128	4	;	;	PUNCT
iajs-3338	128	5	yang	yang	PROPN
iajs-3338	128	6	,	,	PUNCT
iajs-3338	128	7	l.	l.	PROPN
iajs-3338	128	8	;	;	PUNCT
iajs-3338	128	9	wen	wen	PROPN
iajs-3338	128	10	,	,	PUNCT
iajs-3338	128	11	l.	l.	PROPN
iajs-3338	128	12	;	;	PUNCT
iajs-3338	128	13	lu	lu	PROPN
iajs-3338	128	14	,	,	PUNCT
iajs-3338	128	15	h.	h.	PROPN
iajs-3338	128	16	;	;	PUNCT
iajs-3338	128	17	chen	chen	PROPN
iajs-3338	128	18	,	,	PUNCT
iajs-3338	128	19	q.	q.	PROPN
iajs-3338	128	20	;	;	PUNCT
iajs-3338	128	21	wang	wang	PROPN
iajs-3338	128	22	,	,	PUNCT
iajs-3338	128	23	z.	z.	PROPN
iajs-3338	128	24	crosstalk	crosstalk	VERB
iajs-3338	128	25	between	between	ADP
iajs-3338	128	26	the	the	DET
iajs-3338	128	27	oral	oral	ADJ
iajs-3338	128	28	microbiota	microbiota	NOUN
iajs-3338	128	29	,	,	PUNCT
iajs-3338	128	30	mucosal	mucosal	NOUN
iajs-3338	128	31	immunity	immunity	NOUN
iajs-3338	128	32	,	,	PUNCT
iajs-3338	128	33	and	and	CCONJ
iajs-3338	128	34	the	the	DET
iajs-3338	128	35	epithelial	epithelial	ADJ
iajs-3338	128	36	barrier	barrier	NOUN
iajs-3338	128	37	regulates	regulate	VERB
iajs-3338	128	38	oral	oral	ADJ
iajs-3338	128	39	mucosal	mucosal	NOUN
iajs-3338	128	40	disease	disease	NOUN
iajs-3338	128	41	pathogenesis	pathogenesis	NOUN
iajs-3338	128	42	.	.	PUNCT
iajs-3338	129	1	mucosal	mucosal	ADJ
iajs-3338	129	2	immunology	immunology	NOUN
iajs-3338	129	3	2021	2021	NUM
iajs-3338	129	4	,	,	PUNCT
iajs-3338	129	5	14(6	14(6	NOUN
iajs-3338	129	6	)	)	PUNCT
iajs-3338	129	7	,	,	PUNCT
iajs-3338	129	8	1247–1258	1247–1258	NUM
iajs-3338	129	9	.	.	PUNCT
iajs-3338	129	10	https://doi.org/10.1038/s41385-021-00413-7	https://doi.org/10.1038/s41385-021-00413-7	NUM
iajs-3338	129	11	.	.	PUNCT
iajs-3338	130	1	17	17	NUM
iajs-3338	130	2	.	.	X
iajs-3338	131	1	zhang	zhang	PROPN
iajs-3338	131	2	,	,	PUNCT
iajs-3338	131	3	j.m	j.m	PROPN
iajs-3338	131	4	.	.	PROPN
iajs-3338	131	5	;	;	PUNCT
iajs-3338	131	6	an	an	PRON
iajs-3338	131	7	,	,	PUNCT
iajs-3338	131	8	j.	j.	PROPN
iajs-3338	131	9	cytokines	cytokines	PROPN
iajs-3338	131	10	,	,	PUNCT
iajs-3338	131	11	inflammation	inflammation	NOUN
iajs-3338	131	12	,	,	PUNCT
iajs-3338	131	13	and	and	CCONJ
iajs-3338	131	14	pain	pain	NOUN
iajs-3338	131	15	.	.	PUNCT
iajs-3338	132	1	international	international	ADJ
iajs-3338	132	2	anesthesiology	anesthesiology	NOUN
iajs-3338	132	3	clinics	clinic	NOUN
iajs-3338	132	4	2007	2007	NUM
iajs-3338	132	5	,	,	PUNCT
iajs-3338	132	6	45(2	45(2	NOUN
iajs-3338	132	7	)	)	PUNCT
iajs-3338	132	8	,	,	PUNCT
iajs-3338	132	9	27–37	27–37	NUM
iajs-3338	132	10	.	.	PUNCT
iajs-3338	133	1	https://doi.org/10.1097/aia.0b013e318034194e	https://doi.org/10.1097/aia.0b013e318034194e	PROPN
iajs-3338	133	2	.	.	PROPN
iajs-3338	133	3	https://doi.org/10.32007/jfacmedbagdad.532876	https://doi.org/10.32007/jfacmedbagdad.532876	PROPN
iajs-3338	133	4	https://doi.org/10.1016/j.cden.2013.12.002	https://doi.org/10.1016/j.cden.2013.12.002	PROPN
iajs-3338	133	5	https://www.ncbi.nlm.nih.gov/books/nbk431059/	https://www.ncbi.nlm.nih.gov/books/nbk431059/	NOUN
iajs-3338	133	6	https://doi.org/10.26477/jbcd.v34i3.3211	https://doi.org/10.26477/jbcd.v34i3.3211	X
iajs-3338	133	7	https://jbcd.uobaghdad.edu.iq/index.php/jbcd/article/view/204	https://jbcd.uobaghdad.edu.iq/index.php/jbcd/article/view/204	PROPN
iajs-3338	133	8	https://doi.org/10.37506/ijfmt.v14i4.11870	https://doi.org/10.37506/ijfmt.v14i4.11870	AUX
iajs-3338	133	9	https://doi.org/10.1111/jop.13158	https://doi.org/10.1111/jop.13158	VERB
iajs-3338	133	10	https://doi.org/10.4103/jispcd.jispcd_172_21	https://doi.org/10.4103/jispcd.jispcd_172_21	PROPN
iajs-3338	133	11	https://doi.org/10.1111/dth.15500	https://doi.org/10.1111/dth.15500	PROPN
iajs-3338	133	12	https://doi.org/10.4317/jced.51401	https://doi.org/10.4317/jced.51401	NOUN
iajs-3338	133	13	https://doi.org/10.1001/archderm.134.7.827	https://doi.org/10.1001/archderm.134.7.827	PROPN
iajs-3338	133	14	https://doi.org/10.1016/j.mehy.2020.110449	https://doi.org/10.1016/j.mehy.2020.110449	PROPN
iajs-3338	133	15	https://doi.org/10.3390/ijms222212149	https://doi.org/10.3390/ijms222212149	VERB
iajs-3338	133	16	https://doi.org/10.1038/s41385-021-00413-7	https://doi.org/10.1038/s41385-021-00413-7	NUM
iajs-3338	133	17	https://doi.org/10.1097/aia.0b013e318034194e	https://doi.org/10.1097/aia.0b013e318034194e	PROPN
iajs-3338	133	18	ihjpas	ihjpa	NOUN
iajs-3338	133	19	.	.	PUNCT
iajs-3338	134	1	2024	2024	NUM
iajs-3338	134	2	,	,	PUNCT
iajs-3338	134	3	37(4	37(4	NOUN
iajs-3338	134	4	)	)	PUNCT
iajs-3338	134	5	24	24	NUM
iajs-3338	134	6	18	18	NUM
iajs-3338	134	7	.	.	PUNCT
iajs-3338	135	1	lewkowicz	lewkowicz	PROPN
iajs-3338	135	2	,	,	PUNCT
iajs-3338	135	3	n.	n.	NOUN
iajs-3338	135	4	;	;	PUNCT
iajs-3338	135	5	lewkowicz	lewkowicz	NOUN
iajs-3338	135	6	,	,	PUNCT
iajs-3338	135	7	p.	p.	NOUN
iajs-3338	135	8	;	;	PUNCT
iajs-3338	135	9	banasik	banasik	NOUN
iajs-3338	135	10	,	,	PUNCT
iajs-3338	135	11	m.	m.	NOUN
iajs-3338	135	12	;	;	PUNCT
iajs-3338	135	13	kurnatowska	kurnatowska	PROPN
iajs-3338	135	14	,	,	PUNCT
iajs-3338	135	15	a.	a.	NOUN
iajs-3338	135	16	;	;	PUNCT
iajs-3338	135	17	tchórzewski	tchórzewski	NOUN
iajs-3338	135	18	,	,	PUNCT
iajs-3338	135	19	h.	h.	NOUN
iajs-3338	135	20	predominance	predominance	NOUN
iajs-3338	135	21	of	of	ADP
iajs-3338	135	22	type	type	NOUN
iajs-3338	135	23	1	1	NUM
iajs-3338	135	24	cytokines	cytokine	NOUN
iajs-3338	135	25	and	and	CCONJ
iajs-3338	135	26	decreased	decrease	VERB
iajs-3338	135	27	number	number	NOUN
iajs-3338	135	28	of	of	ADP
iajs-3338	135	29	cd4	cd4	PROPN
iajs-3338	135	30	+	+	PROPN
iajs-3338	135	31	cd25	cd25	PROPN
iajs-3338	135	32	+	+	CCONJ
iajs-3338	135	33	high	high	ADJ
iajs-3338	135	34	t	t	NOUN
iajs-3338	135	35	regulatory	regulatory	ADJ
iajs-3338	135	36	cells	cell	NOUN
iajs-3338	135	37	in	in	ADP
iajs-3338	135	38	peripheral	peripheral	ADJ
iajs-3338	135	39	blood	blood	NOUN
iajs-3338	135	40	of	of	ADP
iajs-3338	135	41	patients	patient	NOUN
iajs-3338	135	42	with	with	ADP
iajs-3338	135	43	recurrent	recurrent	ADJ
iajs-3338	135	44	aphthous	aphthous	ADJ
iajs-3338	135	45	ulcerations	ulceration	NOUN
iajs-3338	135	46	.	.	PUNCT
iajs-3338	136	1	immunology	immunology	NOUN
iajs-3338	136	2	letters	letter	NOUN
iajs-3338	136	3	2005	2005	NUM
iajs-3338	136	4	,	,	PUNCT
iajs-3338	136	5	99(1	99(1	NUM
iajs-3338	136	6	)	)	PUNCT
iajs-3338	136	7	,	,	PUNCT
iajs-3338	136	8	57	57	NUM
iajs-3338	136	9	-	-	SYM
iajs-3338	136	10	62	62	NUM
iajs-3338	136	11	.	.	PUNCT
iajs-3338	137	1	https://doi.org/10.1016/j.imlet.2005.01.002	https://doi.org/10.1016/j.imlet.2005.01.002	PROPN
iajs-3338	137	2	.	.	PROPN
iajs-3338	138	1	19	19	NUM
iajs-3338	138	2	.	.	PUNCT
iajs-3338	139	1	albanidou	albanidou	NOUN
iajs-3338	139	2	-	-	PUNCT
iajs-3338	139	3	farmaki	farmaki	PROPN
iajs-3338	139	4	,	,	PUNCT
iajs-3338	139	5	e.	e.	PROPN
iajs-3338	139	6	;	;	PUNCT
iajs-3338	139	7	markopoulos	markopoulos	PROPN
iajs-3338	139	8	,	,	PUNCT
iajs-3338	139	9	a.k	a.k	PROPN
iajs-3338	139	10	.	.	PROPN
iajs-3338	139	11	;	;	PUNCT
iajs-3338	139	12	kalogerakou	kalogerakou	PROPN
iajs-3338	139	13	,	,	PUNCT
iajs-3338	139	14	f.	f.	PROPN
iajs-3338	139	15	;	;	PUNCT
iajs-3338	139	16	antoniades	antoniade	NOUN
iajs-3338	139	17	,	,	PUNCT
iajs-3338	139	18	d.z	d.z	PROPN
iajs-3338	139	19	.	.	PROPN
iajs-3338	139	20	detection	detection	NOUN
iajs-3338	139	21	,	,	PUNCT
iajs-3338	139	22	enumeration	enumeration	NOUN
iajs-3338	139	23	and	and	CCONJ
iajs-3338	139	24	characterization	characterization	NOUN
iajs-3338	139	25	of	of	ADP
iajs-3338	139	26	t	t	PROPN
iajs-3338	139	27	helper	helper	NOUN
iajs-3338	139	28	cells	cell	NOUN
iajs-3338	139	29	secreting	secrete	VERB
iajs-3338	139	30	type	type	NOUN
iajs-3338	139	31	1	1	NUM
iajs-3338	139	32	and	and	CCONJ
iajs-3338	139	33	type	type	NOUN
iajs-3338	139	34	2	2	NUM
iajs-3338	139	35	cytokines	cytokine	NOUN
iajs-3338	139	36	in	in	ADP
iajs-3338	139	37	patients	patient	NOUN
iajs-3338	139	38	with	with	ADP
iajs-3338	139	39	recurrent	recurrent	ADJ
iajs-3338	139	40	aphthous	aphthous	ADJ
iajs-3338	139	41	stomatitis	stomatitis	NOUN
iajs-3338	139	42	.	.	PUNCT
iajs-3338	140	1	the	the	DET
iajs-3338	140	2	tohoku	tohoku	PROPN
iajs-3338	140	3	journal	journal	NOUN
iajs-3338	140	4	of	of	ADP
iajs-3338	140	5	experimental	experimental	ADJ
iajs-3338	140	6	medicine	medicine	NOUN
iajs-3338	140	7	2007	2007	NUM
iajs-3338	140	8	,	,	PUNCT
iajs-3338	140	9	212(2	212(2	NUM
iajs-3338	140	10	)	)	PUNCT
iajs-3338	140	11	,	,	PUNCT
iajs-3338	140	12	101105	101105	NUM
iajs-3338	140	13	.	.	PUNCT
iajs-3338	141	1	https://doi.org/10.1620/tjem.212.101	https://doi.org/10.1620/tjem.212.101	NOUN
iajs-3338	141	2	.	.	PUNCT
iajs-3338	142	1	20	20	NUM
iajs-3338	142	2	.	.	X
iajs-3338	143	1	maiorino	maiorino	PROPN
iajs-3338	143	2	,	,	PUNCT
iajs-3338	143	3	l.	l.	PROPN
iajs-3338	143	4	;	;	PUNCT
iajs-3338	143	5	daßler	daßler	NOUN
iajs-3338	143	6	-	-	PUNCT
iajs-3338	143	7	plenker	plenker	NOUN
iajs-3338	143	8	,	,	PUNCT
iajs-3338	143	9	j.	j.	PROPN
iajs-3338	143	10	;	;	PUNCT
iajs-3338	143	11	sun	sun	PROPN
iajs-3338	143	12	,	,	PUNCT
iajs-3338	143	13	l.	l.	PROPN
iajs-3338	143	14	;	;	PUNCT
iajs-3338	143	15	egeblad	egeblad	NOUN
iajs-3338	143	16	,	,	PUNCT
iajs-3338	143	17	m.	m.	NOUN
iajs-3338	143	18	innate	innate	ADJ
iajs-3338	143	19	immunity	immunity	NOUN
iajs-3338	143	20	and	and	CCONJ
iajs-3338	143	21	cancer	cancer	NOUN
iajs-3338	143	22	pathophysiology	pathophysiology	NOUN
iajs-3338	143	23	.	.	PUNCT
iajs-3338	144	1	annual	annual	ADJ
iajs-3338	144	2	review	review	NOUN
iajs-3338	144	3	of	of	ADP
iajs-3338	144	4	pathology	pathology	NOUN
iajs-3338	144	5	2022	2022	NUM
iajs-3338	144	6	,	,	PUNCT
iajs-3338	144	7	17	17	NUM
iajs-3338	144	8	,	,	PUNCT
iajs-3338	144	9	425–457	425–457	NUM
iajs-3338	144	10	.	.	PUNCT
iajs-3338	145	1	https://doi.org/10.1146/annurev-pathmechdis-032221115501	https://doi.org/10.1146/annurev-pathmechdis-032221115501	NOUN
iajs-3338	145	2	.	.	PUNCT
iajs-3338	146	1	21	21	NUM
iajs-3338	146	2	.	.	PUNCT
iajs-3338	147	1	zhu	zhu	PROPN
iajs-3338	147	2	j.	j.	PROPN
iajs-3338	147	3	t	t	PROPN
iajs-3338	147	4	helper	helper	NOUN
iajs-3338	147	5	2	2	NUM
iajs-3338	147	6	(	(	PUNCT
iajs-3338	147	7	th2	th2	PROPN
iajs-3338	147	8	)	)	PUNCT
iajs-3338	147	9	cell	cell	NOUN
iajs-3338	147	10	differentiation	differentiation	NOUN
iajs-3338	147	11	,	,	PUNCT
iajs-3338	147	12	type	type	NOUN
iajs-3338	147	13	2	2	NUM
iajs-3338	147	14	innate	innate	ADJ
iajs-3338	147	15	lymphoid	lymphoid	NOUN
iajs-3338	147	16	cell	cell	NOUN
iajs-3338	147	17	(	(	PUNCT
iajs-3338	147	18	ilc2	ilc2	NOUN
iajs-3338	147	19	)	)	PUNCT
iajs-3338	147	20	development	development	NOUN
iajs-3338	147	21	and	and	CCONJ
iajs-3338	147	22	regulation	regulation	NOUN
iajs-3338	147	23	of	of	ADP
iajs-3338	147	24	interleukin-4	interleukin-4	PROPN
iajs-3338	147	25	(	(	PUNCT
iajs-3338	147	26	il-4	il-4	NUM
iajs-3338	147	27	)	)	PUNCT
iajs-3338	147	28	and	and	CCONJ
iajs-3338	147	29	il-13	il-13	ADP
iajs-3338	147	30	production	production	NOUN
iajs-3338	147	31	.	.	PUNCT
iajs-3338	148	1	cytokine	cytokine	NOUN
iajs-3338	148	2	2015	2015	NUM
iajs-3338	148	3	,	,	PUNCT
iajs-3338	148	4	75(1	75(1	NOUN
iajs-3338	148	5	)	)	PUNCT
iajs-3338	148	6	,	,	PUNCT
iajs-3338	148	7	14–24	14–24	NUM
iajs-3338	148	8	.	.	PUNCT
iajs-3338	149	1	https://doi.org/10.1016/j.cyto.2015.05.010	https://doi.org/10.1016/j.cyto.2015.05.010	PROPN
iajs-3338	149	2	.	.	PUNCT
iajs-3338	150	1	22	22	NUM
iajs-3338	150	2	.	.	X
iajs-3338	150	3	ross	ross	PROPN
iajs-3338	150	4	,	,	PUNCT
iajs-3338	150	5	s.h	s.h	PROPN
iajs-3338	150	6	.	.	PROPN
iajs-3338	150	7	;	;	PUNCT
iajs-3338	150	8	cantrell	cantrell	PROPN
iajs-3338	150	9	,	,	PUNCT
iajs-3338	150	10	d.a	d.a	PROPN
iajs-3338	150	11	.	.	NOUN
iajs-3338	150	12	signaling	signal	VERB
iajs-3338	150	13	and	and	CCONJ
iajs-3338	150	14	function	function	NOUN
iajs-3338	150	15	of	of	ADP
iajs-3338	150	16	interleukin-2	interleukin-2	NOUN
iajs-3338	150	17	in	in	ADP
iajs-3338	150	18	t	t	NOUN
iajs-3338	150	19	lymphocytes	lymphocyte	NOUN
iajs-3338	150	20	.	.	PUNCT
iajs-3338	151	1	annual	annual	ADJ
iajs-3338	151	2	review	review	NOUN
iajs-3338	151	3	of	of	ADP
iajs-3338	151	4	immunology	immunology	NOUN
iajs-3338	151	5	2018	2018	NUM
iajs-3338	151	6	,	,	PUNCT
iajs-3338	151	7	36	36	NUM
iajs-3338	151	8	,	,	PUNCT
iajs-3338	151	9	411–433	411–433	NUM
iajs-3338	151	10	.	.	PUNCT
iajs-3338	152	1	https://doi.org/10.1146/annurev-immunol-042617-053352	https://doi.org/10.1146/annurev-immunol-042617-053352	NOUN
iajs-3338	152	2	.	.	PROPN
iajs-3338	153	1	23	23	NUM
iajs-3338	153	2	.	.	PUNCT
iajs-3338	154	1	al	al	PROPN
iajs-3338	154	2	-	-	PUNCT
iajs-3338	154	3	khateeb	khateeb	PROPN
iajs-3338	154	4	,	,	PUNCT
iajs-3338	154	5	s.m	s.m	PROPN
iajs-3338	154	6	.	.	PROPN
iajs-3338	154	7	;	;	PUNCT
iajs-3338	154	8	tahir	tahir	PROPN
iajs-3338	154	9	,	,	PUNCT
iajs-3338	154	10	n.	n.	PROPN
iajs-3338	154	11	t.	t.	PROPN
iajs-3338	154	12	;	;	PUNCT
iajs-3338	154	13	al	al	PROPN
iajs-3338	154	14	-	-	PUNCT
iajs-3338	154	15	bayati	bayati	PROPN
iajs-3338	154	16	,	,	PUNCT
iajs-3338	154	17	a.	a.	PROPN
iajs-3338	154	18	a.	a.	PROPN
iajs-3338	154	19	h.	h.	PROPN
iajs-3338	154	20	immune	immune	PROPN
iajs-3338	154	21	and	and	CCONJ
iajs-3338	154	22	inflammatory	inflammatory	ADJ
iajs-3338	154	23	cytokines	cytokine	NOUN
iajs-3338	154	24	profile	profile	ADV
iajs-3338	154	25	in	in	ADP
iajs-3338	154	26	iraqi	iraqi	ADJ
iajs-3338	154	27	patients	patient	NOUN
iajs-3338	154	28	with	with	ADP
iajs-3338	154	29	acute	acute	ADJ
iajs-3338	154	30	and	and	CCONJ
iajs-3338	154	31	chronic	chronic	ADJ
iajs-3338	154	32	myeloid	myeloid	NOUN
iajs-3338	154	33	leukemia	leukemia	NOUN
iajs-3338	154	34	.	.	PUNCT
iajs-3338	155	1	biomedicine	biomedicine	NOUN
iajs-3338	155	2	2022	2022	NUM
iajs-3338	155	3	,	,	PUNCT
iajs-3338	155	4	42(2	42(2	NOUN
iajs-3338	155	5	)	)	PUNCT
iajs-3338	155	6	,	,	PUNCT
iajs-3338	155	7	262267	262267	NUM
iajs-3338	155	8	.	.	PUNCT
iajs-3338	156	1	https://doi.org/10.51248/.v42i2.1321	https://doi.org/10.51248/.v42i2.1321	X
iajs-3338	156	2	.	.	PROPN
iajs-3338	156	3	24	24	NUM
iajs-3338	156	4	.	.	PUNCT
iajs-3338	157	1	saud	saud	PROPN
iajs-3338	157	2	,	,	PUNCT
iajs-3338	157	3	a.m.	a.m.	PROPN
iajs-3338	157	4	serum	serum	PROPN
iajs-3338	157	5	levels	level	NOUN
iajs-3338	157	6	of	of	ADP
iajs-3338	157	7	tumor	tumor	NOUN
iajs-3338	157	8	necrosis	necrosis	NOUN
iajs-3338	157	9	factor	factor	NOUN
iajs-3338	157	10	alpha	alpha	NOUN
iajs-3338	157	11	and	and	CCONJ
iajs-3338	157	12	interleukin-12	interleukin-12	NOUN
iajs-3338	157	13	in	in	ADP
iajs-3338	157	14	some	some	DET
iajs-3338	157	15	iraqi	iraqi	ADJ
iajs-3338	157	16	diabetic	diabetic	ADJ
iajs-3338	157	17	patients	patient	NOUN
iajs-3338	157	18	type	type	VERB
iajs-3338	157	19	i.	i.	PROPN
iajs-3338	157	20	international	international	PROPN
iajs-3338	157	21	journal	journal	PROPN
iajs-3338	157	22	of	of	ADP
iajs-3338	157	23	current	current	ADJ
iajs-3338	157	24	microbiology	microbiology	NOUN
iajs-3338	157	25	and	and	CCONJ
iajs-3338	157	26	applied	apply	VERB
iajs-3338	157	27	science	science	NOUN
iajs-3338	157	28	2014	2014	NUM
iajs-3338	157	29	,	,	PUNCT
iajs-3338	157	30	3(4	3(4	NUM
iajs-3338	157	31	)	)	PUNCT
iajs-3338	157	32	,	,	PUNCT
iajs-3338	157	33	260	260	NUM
iajs-3338	157	34	-	-	SYM
iajs-3338	157	35	268	268	NUM
iajs-3338	157	36	.	.	PUNCT
iajs-3338	158	1	25	25	NUM
iajs-3338	158	2	.	.	PUNCT
iajs-3338	159	1	liu	liu	PROPN
iajs-3338	159	2	,	,	PUNCT
iajs-3338	159	3	j.	j.	PROPN
iajs-3338	159	4	;	;	PUNCT
iajs-3338	159	5	cao	cao	PROPN
iajs-3338	159	6	,	,	PUNCT
iajs-3338	159	7	s.	s.	PROPN
iajs-3338	159	8	;	;	PUNCT
iajs-3338	159	9	kim	kim	PROPN
iajs-3338	159	10	,	,	PUNCT
iajs-3338	159	11	s.	s.	PROPN
iajs-3338	159	12	;	;	PUNCT
iajs-3338	159	13	chung	chung	PROPN
iajs-3338	159	14	,	,	PUNCT
iajs-3338	159	15	e.y	e.y	PROPN
iajs-3338	159	16	.	.	PROPN
iajs-3338	159	17	;	;	PUNCT
iajs-3338	159	18	homma	homma	PROPN
iajs-3338	159	19	,	,	PUNCT
iajs-3338	159	20	y.	y.	PROPN
iajs-3338	159	21	;	;	PUNCT
iajs-3338	159	22	guan	guan	PROPN
iajs-3338	159	23	,	,	PUNCT
iajs-3338	159	24	x.	x.	PROPN
iajs-3338	159	25	;	;	PUNCT
iajs-3338	159	26	jimenez	jimenez	PROPN
iajs-3338	159	27	,	,	PUNCT
iajs-3338	159	28	v.	v.	PROPN
iajs-3338	159	29	;	;	PUNCT
iajs-3338	159	30	ma	ma	PROPN
iajs-3338	159	31	,	,	PUNCT
iajs-3338	159	32	x.	x.	PROPN
iajs-3338	159	33	interleukin-12	interleukin-12	PROPN
iajs-3338	159	34	:	:	PUNCT
iajs-3338	159	35	an	an	DET
iajs-3338	159	36	update	update	NOUN
iajs-3338	159	37	on	on	ADP
iajs-3338	159	38	its	its	PRON
iajs-3338	159	39	immunological	immunological	ADJ
iajs-3338	159	40	activities	activity	NOUN
iajs-3338	159	41	,	,	PUNCT
iajs-3338	159	42	signaling	signal	VERB
iajs-3338	159	43	and	and	CCONJ
iajs-3338	159	44	regulation	regulation	NOUN
iajs-3338	159	45	of	of	ADP
iajs-3338	159	46	gene	gene	NOUN
iajs-3338	159	47	expression	expression	NOUN
iajs-3338	159	48	.	.	PUNCT
iajs-3338	160	1	current	current	ADJ
iajs-3338	160	2	immunology	immunology	NOUN
iajs-3338	160	3	reviews	review	NOUN
iajs-3338	160	4	2005	2005	NUM
iajs-3338	160	5	,	,	PUNCT
iajs-3338	160	6	1(2	1(2	NUM
iajs-3338	160	7	)	)	PUNCT
iajs-3338	160	8	,	,	PUNCT
iajs-3338	160	9	119–137	119–137	NUM
iajs-3338	160	10	.	.	PUNCT
iajs-3338	161	1	https://doi.org/10.2174/1573395054065115	https://doi.org/10.2174/1573395054065115	X
iajs-3338	161	2	.	.	PUNCT
iajs-3338	162	1	26	26	NUM
iajs-3338	162	2	.	.	X
iajs-3338	163	1	mishra	mishra	PROPN
iajs-3338	163	2	,	,	PUNCT
iajs-3338	163	3	p.	p.	PROPN
iajs-3338	163	4	;	;	PUNCT
iajs-3338	163	5	pandey	pandey	PROPN
iajs-3338	163	6	,	,	PUNCT
iajs-3338	163	7	c.m	c.m	PROPN
iajs-3338	163	8	.	.	PROPN
iajs-3338	163	9	;	;	PUNCT
iajs-3338	163	10	singh	singh	PROPN
iajs-3338	163	11	,	,	PUNCT
iajs-3338	163	12	u.	u.	PROPN
iajs-3338	163	13	;	;	PUNCT
iajs-3338	163	14	gupta	gupta	PROPN
iajs-3338	163	15	,	,	PUNCT
iajs-3338	163	16	a.	a.	NOUN
iajs-3338	163	17	;	;	PUNCT
iajs-3338	163	18	sahu	sahu	PROPN
iajs-3338	163	19	,	,	PUNCT
iajs-3338	163	20	c.	c.	PROPN
iajs-3338	163	21	;	;	PUNCT
iajs-3338	163	22	keshri	keshri	PROPN
iajs-3338	163	23	,	,	PUNCT
iajs-3338	163	24	a.	a.	PROPN
iajs-3338	163	25	descriptive	descriptive	ADJ
iajs-3338	163	26	statistics	statistic	NOUN
iajs-3338	163	27	and	and	CCONJ
iajs-3338	163	28	normality	normality	NOUN
iajs-3338	163	29	tests	test	NOUN
iajs-3338	163	30	for	for	ADP
iajs-3338	163	31	statistical	statistical	ADJ
iajs-3338	163	32	data	datum	NOUN
iajs-3338	163	33	.	.	PUNCT
iajs-3338	164	1	annals	annal	NOUN
iajs-3338	164	2	of	of	ADP
iajs-3338	164	3	cardiac	cardiac	ADJ
iajs-3338	164	4	anaesthesia	anaesthesia	NOUN
iajs-3338	164	5	2019	2019	NUM
iajs-3338	164	6	,	,	PUNCT
iajs-3338	164	7	22(1	22(1	NUM
iajs-3338	164	8	)	)	PUNCT
iajs-3338	164	9	,	,	PUNCT
iajs-3338	164	10	67–72	67–72	NUM
iajs-3338	164	11	.	.	PUNCT
iajs-3338	164	12	https://doi.org/10.4103/aca.aca_157_18	https://doi.org/10.4103/aca.aca_157_18	PROPN
iajs-3338	164	13	.	.	PUNCT
iajs-3338	165	1	27	27	NUM
iajs-3338	165	2	.	.	PUNCT
iajs-3338	166	1	bhosale	bhosale	PROPN
iajs-3338	166	2	,	,	PUNCT
iajs-3338	166	3	s.s	s.s	PROPN
iajs-3338	166	4	.	.	PROPN
iajs-3338	166	5	;	;	PUNCT
iajs-3338	167	1	rajput	rajput	PROPN
iajs-3338	167	2	,	,	PUNCT
iajs-3338	167	3	b.s	b.s	PROPN
iajs-3338	167	4	.	.	PROPN
iajs-3338	167	5	;	;	PUNCT
iajs-3338	167	6	takkar	takkar	NOUN
iajs-3338	167	7	,	,	PUNCT
iajs-3338	167	8	h.	h.	PROPN
iajs-3338	167	9	;	;	PUNCT
iajs-3338	167	10	bhagat	bhagat	PROPN
iajs-3338	167	11	,	,	PUNCT
iajs-3338	167	12	s.v	s.v	PROPN
iajs-3338	167	13	.	.	PROPN
iajs-3338	167	14	;	;	PUNCT
iajs-3338	167	15	vagger	vagger	NOUN
iajs-3338	167	16	,	,	PUNCT
iajs-3338	167	17	r.m	r.m	PROPN
iajs-3338	167	18	.	.	PROPN
iajs-3338	167	19	;	;	PUNCT
iajs-3338	167	20	shaikh	shaikh	PROPN
iajs-3338	167	21	,	,	PUNCT
iajs-3338	167	22	m.i.k	m.i.k	NOUN
iajs-3338	167	23	.	.	PUNCT
iajs-3338	167	24	establishment	establishment	NOUN
iajs-3338	167	25	of	of	ADP
iajs-3338	167	26	role	role	NOUN
iajs-3338	167	27	of	of	ADP
iajs-3338	167	28	il-2	il-2	NOUN
iajs-3338	167	29	,	,	PUNCT
iajs-3338	167	30	il-10	il-10	NOUN
iajs-3338	167	31	and	and	CCONJ
iajs-3338	167	32	il-12	il-12	NOUN
iajs-3338	167	33	in	in	ADP
iajs-3338	167	34	patients	patient	NOUN
iajs-3338	167	35	with	with	ADP
iajs-3338	167	36	recurrent	recurrent	ADJ
iajs-3338	167	37	aphthous	aphthous	ADJ
iajs-3338	167	38	stomatitis	stomatitis	NOUN
iajs-3338	167	39	-	-	PUNCT
iajs-3338	167	40	a	a	DET
iajs-3338	167	41	clinical	clinical	ADJ
iajs-3338	167	42	study	study	NOUN
iajs-3338	167	43	.	.	PUNCT
iajs-3338	168	1	journal	journal	PROPN
iajs-3338	168	2	of	of	ADP
iajs-3338	168	3	contemporary	contemporary	ADJ
iajs-3338	168	4	dental	dental	ADJ
iajs-3338	168	5	practice	practice	NOUN
iajs-3338	168	6	2018	2018	NUM
iajs-3338	168	7	,	,	PUNCT
iajs-3338	168	8	19(10	19(10	NUM
iajs-3338	168	9	)	)	PUNCT
iajs-3338	168	10	,	,	PUNCT
iajs-3338	168	11	1242	1242	NUM
iajs-3338	168	12	-	-	SYM
iajs-3338	168	13	1245	1245	NUM
iajs-3338	168	14	.	.	PUNCT
iajs-3338	169	1	28	28	NUM
iajs-3338	169	2	.	.	PUNCT
iajs-3338	170	1	scully	scully	PROPN
iajs-3338	170	2	,	,	PUNCT
iajs-3338	170	3	c.	c.	PROPN
iajs-3338	170	4	;	;	PUNCT
iajs-3338	170	5	gorsky	gorsky	NOUN
iajs-3338	170	6	,	,	PUNCT
iajs-3338	170	7	m.	m.	NOUN
iajs-3338	170	8	;	;	PUNCT
iajs-3338	170	9	lozada	lozada	PROPN
iajs-3338	170	10	-	-	PUNCT
iajs-3338	170	11	nur	nur	PROPN
iajs-3338	170	12	,	,	PUNCT
iajs-3338	170	13	f.	f.	NOUN
iajs-3338	170	14	the	the	DET
iajs-3338	170	15	diagnosis	diagnosis	NOUN
iajs-3338	170	16	and	and	CCONJ
iajs-3338	170	17	management	management	NOUN
iajs-3338	170	18	of	of	ADP
iajs-3338	170	19	recurrent	recurrent	ADJ
iajs-3338	170	20	aphthous	aphthous	ADJ
iajs-3338	170	21	stomatitis	stomatitis	NOUN
iajs-3338	170	22	:	:	PUNCT
iajs-3338	170	23	a	a	DET
iajs-3338	170	24	consensus	consensus	NOUN
iajs-3338	170	25	approach	approach	NOUN
iajs-3338	170	26	.	.	PUNCT
iajs-3338	171	1	journal	journal	NOUN
iajs-3338	171	2	of	of	ADP
iajs-3338	171	3	the	the	DET
iajs-3338	171	4	american	american	PROPN
iajs-3338	171	5	dental	dental	PROPN
iajs-3338	171	6	association	association	NOUN
iajs-3338	171	7	2003	2003	NUM
iajs-3338	171	8	,	,	PUNCT
iajs-3338	171	9	134(2	134(2	NUM
iajs-3338	171	10	)	)	PUNCT
iajs-3338	171	11	,	,	PUNCT
iajs-3338	171	12	200–207	200–207	NUM
iajs-3338	171	13	.	.	PUNCT
iajs-3338	172	1	https://doi.org/10.14219/jada.archive.2003.0134	https://doi.org/10.14219/jada.archive.2003.0134	PROPN
iajs-3338	172	2	.	.	PROPN
iajs-3338	172	3	29	29	NUM
iajs-3338	172	4	.	.	PUNCT
iajs-3338	173	1	lewkowicz	lewkowicz	PROPN
iajs-3338	173	2	,	,	PUNCT
iajs-3338	173	3	n.	n.	NOUN
iajs-3338	173	4	;	;	PUNCT
iajs-3338	173	5	banasik	banasik	ADJ
iajs-3338	173	6	,	,	PUNCT
iajs-3338	173	7	m.	m.	NOUN
iajs-3338	173	8	;	;	PUNCT
iajs-3338	173	9	tchórzewski	tchórzewski	NOUN
iajs-3338	173	10	,	,	PUNCT
iajs-3338	173	11	h.	h.	PROPN
iajs-3338	173	12	;	;	PUNCT
iajs-3338	173	13	kurnatowska	kurnatowska	PROPN
iajs-3338	173	14	,	,	PUNCT
iajs-3338	173	15	a	a	DET
iajs-3338	173	16	j.	j.	PROPN
iajs-3338	173	17	;	;	PUNCT
iajs-3338	173	18	lewkowicz	lewkowicz	PROPN
iajs-3338	173	19	,	,	PUNCT
iajs-3338	173	20	p.	p.	NOUN
iajs-3338	173	21	predominance	predominance	NOUN
iajs-3338	173	22	of	of	ADP
iajs-3338	173	23	production	production	NOUN
iajs-3338	173	24	of	of	ADP
iajs-3338	173	25	th1	th1	NOUN
iajs-3338	173	26	type	type	NOUN
iajs-3338	173	27	cytokines	cytokine	NOUN
iajs-3338	173	28	in	in	ADP
iajs-3338	173	29	recurrent	recurrent	ADJ
iajs-3338	173	30	aphthous	aphthous	ADJ
iajs-3338	173	31	ulceration	ulceration	NOUN
iajs-3338	173	32	.	.	PUNCT
iajs-3338	174	1	dental	dental	ADJ
iajs-3338	174	2	and	and	CCONJ
iajs-3338	174	3	medical	medical	ADJ
iajs-3338	174	4	problems	problem	NOUN
iajs-3338	174	5	2004	2004	NUM
iajs-3338	174	6	,	,	PUNCT
iajs-3338	174	7	42	42	NUM
iajs-3338	174	8	,	,	PUNCT
iajs-3338	174	9	655	655	NUM
iajs-3338	174	10	-	-	SYM
iajs-3338	174	11	60	60	NUM
iajs-3338	174	12	.	.	PUNCT
iajs-3338	174	13	30	30	NUM
iajs-3338	174	14	.	.	PUNCT
iajs-3338	175	1	borra	borra	PROPN
iajs-3338	175	2	,	,	PUNCT
iajs-3338	175	3	r.c	r.c	PROPN
iajs-3338	175	4	.	.	PROPN
iajs-3338	175	5	;	;	PUNCT
iajs-3338	175	6	andrade	andrade	PROPN
iajs-3338	175	7	,	,	PUNCT
iajs-3338	175	8	p.m.	p.m.	NOUN
iajs-3338	175	9	;	;	PUNCT
iajs-3338	175	10	silva	silva	PROPN
iajs-3338	175	11	,	,	PUNCT
iajs-3338	175	12	i.d.c.g	i.d.c.g	PROPN
iajs-3338	175	13	.	.	PROPN
iajs-3338	175	14	;	;	PUNCT
iajs-3338	175	15	morgun	morgun	PROPN
iajs-3338	175	16	,	,	PUNCT
iajs-3338	175	17	a.	a.	NOUN
iajs-3338	175	18	;	;	PUNCT
iajs-3338	175	19	weckx	weckx	ADJ
iajs-3338	175	20	,	,	PUNCT
iajs-3338	175	21	l.l.m	l.l.m	NOUN
iajs-3338	175	22	.	.	PUNCT
iajs-3338	175	23	;	;	PUNCT
iajs-3338	175	24	smirnova	smirnova	X
iajs-3338	175	25	,	,	PUNCT
iajs-3338	175	26	a.s	a.s	PROPN
iajs-3338	175	27	.	.	PROPN
iajs-3338	175	28	;	;	PUNCT
iajs-3338	175	29	franco	franco	PROPN
iajs-3338	175	30	,	,	PUNCT
iajs-3338	175	31	m.	m.	NOUN
iajs-3338	175	32	the	the	DET
iajs-3338	175	33	th1	th1	PROPN
iajs-3338	175	34	/	/	SYM
iajs-3338	175	35	th2	th2	PROPN
iajs-3338	175	36	immune‐type	immune‐type	VERB
iajs-3338	175	37	response	response	NOUN
iajs-3338	175	38	of	of	ADP
iajs-3338	175	39	the	the	DET
iajs-3338	175	40	recurrent	recurrent	ADJ
iajs-3338	175	41	aphthous	aphthous	ADJ
iajs-3338	175	42	ulceration	ulceration	NOUN
iajs-3338	175	43	analyzed	analyze	VERB
iajs-3338	175	44	by	by	ADP
iajs-3338	175	45	cdna	cdna	PROPN
iajs-3338	175	46	microarray	microarray	NOUN
iajs-3338	175	47	.	.	PUNCT
iajs-3338	176	1	journal	journal	NOUN
iajs-3338	176	2	of	of	ADP
iajs-3338	176	3	oral	oral	ADJ
iajs-3338	176	4	pathology	pathology	NOUN
iajs-3338	176	5	&	&	CCONJ
iajs-3338	176	6	medicine	medicine	PROPN
iajs-3338	176	7	2004	2004	NUM
iajs-3338	176	8	,	,	PUNCT
iajs-3338	176	9	33(3	33(3	NOUN
iajs-3338	176	10	)	)	PUNCT
iajs-3338	176	11	,	,	PUNCT
iajs-3338	176	12	140	140	NUM
iajs-3338	176	13	-	-	SYM
iajs-3338	176	14	146	146	NUM
iajs-3338	176	15	.	.	PUNCT
iajs-3338	177	1	https://doi.org/10.1111/j.0904-2512.2004.00089.x	https://doi.org/10.1111/j.0904-2512.2004.00089.x	PROPN
iajs-3338	177	2	.	.	PUNCT
iajs-3338	178	1	https://doi.org/10.1016/j.imlet.2005.01.002	https://doi.org/10.1016/j.imlet.2005.01.002	ADP
iajs-3338	178	2	https://doi.org/10.1620/tjem.212.101	https://doi.org/10.1620/tjem.212.101	PROPN
iajs-3338	178	3	https://doi.org/10.1146/annurev-pathmechdis-032221-115501	https://doi.org/10.1146/annurev-pathmechdis-032221-115501	PROPN
iajs-3338	178	4	https://doi.org/10.1146/annurev-pathmechdis-032221-115501	https://doi.org/10.1146/annurev-pathmechdis-032221-115501	PROPN
iajs-3338	178	5	https://doi.org/10.1016/j.cyto.2015.05.010	https://doi.org/10.1016/j.cyto.2015.05.010	NOUN
iajs-3338	178	6	https://doi.org/10.1146/annurev-immunol-042617-053352	https://doi.org/10.1146/annurev-immunol-042617-053352	PROPN
iajs-3338	178	7	https://doi.org/10.51248/.v42i2.1321	https://doi.org/10.51248/.v42i2.1321	PRON
iajs-3338	178	8	https://doi.org/10.2174/1573395054065115	https://doi.org/10.2174/1573395054065115	NUM
iajs-3338	178	9	https://doi.org/10.4103/aca.aca_157_18	https://doi.org/10.4103/aca.aca_157_18	PROPN
iajs-3338	179	1	https://doi.org/10.14219/jada.archive.2003.0134	https://doi.org/10.14219/jada.archive.2003.0134	PROPN
iajs-3338	179	2	https://doi.org/10.1111/j.0904-2512.2004.00089.x	https://doi.org/10.1111/j.0904-2512.2004.00089.x	PROPN
iajs-3338	179	3	abstract	abstract	ADJ
iajs-3338	180	1	1	1	NUM
iajs-3338	180	2	.	.	PUNCT
iajs-3338	180	3	introduction	introduction	NOUN
iajs-3338	180	4	2	2	NUM
iajs-3338	180	5	.	.	PUNCT
iajs-3338	180	6	materials	material	NOUN
iajs-3338	180	7	and	and	CCONJ
iajs-3338	180	8	methods	method	NOUN
iajs-3338	180	9	3	3	NUM
iajs-3338	180	10	.	.	PUNCT
iajs-3338	180	11	results	result	VERB
iajs-3338	180	12	4	4	NUM
iajs-3338	180	13	.	.	PUNCT
iajs-3338	180	14	discussion	discussion	NOUN
iajs-3338	180	15	5	5	NUM
iajs-3338	180	16	.	.	PUNCT
iajs-3338	181	1	conclusions	conclusion	NOUN
iajs-3338	181	2	references	reference	NOUN